![]() respiratory treatment device
专利摘要:
OSCILLATING POSITIVE EXPIRATORY PRESSURE DEVICE This is a respiratory treatment device comprising at least one chamber, a chamber inlet configured to receive exhaled air in at least one chamber, at least one chamber outlet configured to allow exhaled air to escape from the chamber. at least one chamber, and a defined exhalation flow path between the chamber inlet and at least one chamber outlet. A limiting element positioned in the exhalation flow path is movable between a closed position, in which an exhaled air flow along the exhalation flow path is limited, and an open position, in which the exhaled air flow along the exhalation flow path is less limited. A vane in fluid communication with the exhalation flow path is operatively connected to the limiting element and is configured to switch between a first position and a second position in response to the exhaled air flow along the exhalation flow path. 公开号:BR112013031207B1 申请号:R112013031207-6 申请日:2012-06-06 公开日:2020-12-08 发明作者:Adam Meyer;Dan Engelbreth 申请人:Trudell Medical International; IPC主号:
专利说明:
RELATED REQUESTS [0001] This order claims the benefit of Provisional Order No. 61 / 532,951, filed on September 9, 2011, pending, and Provisional Order No. 61 / 493,816, filed on June 6, 2011, pending, both of which are incorporated herein. reference document. TECHNICAL FIELD [0002] The present description relates to a respiratory treatment device and, in particular, to an oscillating positive expiratory pressure device (“OPEC”). BACKGROUND [0003] Every day, human beings can produce more than 30 milliliters of sputum, which is a type of bronchial secretion. Normally, an effective cough is sufficient to release secretions and clear them from the body's airways. However, for individuals who suffer from more significant bronchial obstructions, such as a collapsed airway, a single cough may not be enough to clear the obstructions. [0004] OPEC therapy represents an effective bronchial hygiene technique for the removal of bronchial secretions in the human body and is an important aspect in the treatment and ongoing care of patients with bronchial obstructions, such as those suffering from chronic obstructive pulmonary disease. It is believed that OPEC therapy, or the fluctuation of exhalation pressure in the mouth during exhalation, effectively transmits an oscillating counter pressure to the lungs, thus opening the obstructed airways and releasing secretions that contribute to bronchial obstructions. [0005] OPEC therapy is an attractive form of treatment because it can be easily taught to most patients, and such patients can take responsibility for administering OPEC therapy throughout hospitalization and also at home. To that end, several portable OPEC devices have been developed. BRIEF SUMMARY [0006] In order to provide an effective means for delivering OPEC therapy, a method and device for administering OPEC therapy is described. In a first aspect, a respiratory treatment device includes a housing that encloses at least one chamber, a chamber inlet configured to receive exhaled air within at least one chamber, at least one chamber outlet configured to allow the exhaled air to escape at least one chamber, and a defined exhalation flow path between the chamber inlet and at least one chamber outlet. A limiting element positioned in the exhalation flow path is movable between a closed position, in which an exhaled air flow along the exhalation flow path is limited, and an open position, in which the exhaled air flow along the exhalation flow path is less limited. Additionally, a vane in fluid communication with the exhalation flow path is operatively connected to the limiting element and is configured to switch between a first position and a second position in response to an exhaled air flow along the exhalation flow path. . The limiting element and the blade are axially displaced along a common axis of rotation. [0007] In another aspect, in the first position, the reed is positioned to direct the exhaled air flow out of at least one chamber through a first chamber outlet of at least one chamber outlet, and in the second position, the reed is positioned to direct the flow of exhaled air to exit the at least one chamber through a second chamber outlet from the at least one chamber outlet. [0008] In another aspect, the limiting element is positioned in a first chamber, while the reed is positioned in a second chamber. The first chamber and the second chamber can be connected through an orifice, and the size of the orifice can be configured to change in response to the flow of air exhaled through the orifice. The limiting element can be implanted as a butterfly valve. In addition, the limiting element can be operatively connected to the limiting element by an axis. [0009] In yet another aspect, a face of the limiting element is rotatable around a geometric axis of rotation. The face of the limiting element can also be moved radially from the axis of rotation. In addition, the face of the limiting element may have a larger surface area positioned on one side of the axis than the other side of the axis. [00010] In another aspect, an orientation of the camera input is selectively adjustable. [00011] In an additional aspect, the respiratory treatment device includes a chamber inlet bypass configured to allow air to be exhaled into at least one chamber without passing through the chamber inlet. [00012] In another aspect, the respiratory treatment device includes a control port configured to allow exhaled air to exit the respiratory treatment device before entering at least one chamber. The respiratory treatment device may also include a control port configured to allow exhaled air to escape from the first chamber. [00013] In an additional aspect, the respiratory treatment device includes an inhalation port in fluid communication with a user interface. The respiratory treatment device may also include a check valve configured to allow air to flow through the inhalation port to the user interface upon inhalation. The inhalation port can be adapted to receive an aerosol medication from an aerosol dispensing device. The aerosol dispensing device is connected to the inhalation port. [00014] In another aspect, the exhalation flow path is doubled over itself. [00015] In another aspect, a respiratory treatment device includes a housing that encloses at least one chamber, a chamber inlet configured to receive exhaled air into at least one chamber, at least one chamber outlet configured to allow air exhaled exits at least one chamber, and a defined exhalation flow path between the chamber inlet and at least one chamber outlet. A limiting element positioned in the exhalation flow path is movable between a closed position, in which an exhaled air flow through the chamber inlet is limited, and an open position, in which the exhaled air flow through the chamber inlet is less limited. In addition, an orifice is positioned along the exhalation flow path through which the exhaled air passes. A vane positioned adjacent to the orifice is operatively connected to the limiting member and is configured to switch between a first position and a second position in response to increased pressure adjacent to the vane. The limiting element moves between the closed position and the open position in response to the reed that alternates between the first position and the second position. [00016] In an additional aspect, the limiting element can be positioned in a first chamber and the reed can be positioned in a second chamber, with the orifice separating the first and the second chamber. In addition, the orifice size can be configured to change in response to the flow of air exhaled through the orifice. [00017] In another aspect, a respiratory treatment device includes a housing that encloses at least one chamber, a chamber inlet configured to receive exhaled to at least one chamber, at least one chamber outlet configured to allow exhaled air to exit. at least one chamber, and a defined exhalation flow path between the chamber inlet and at least one chamber outlet. A limiting element positioned on the exhalation flow path is mobile in response to an exhaled air flow along the exhalation flow path between a closed position, in which the exhaled air flow along the exhalation flow path is limited , and an open position, in which the flow of exhaled air along the exhalation flow path is less limited. In addition, a variable nozzle is positioned in the exhalation flow path so that the exhalation flow path passes through a variable nozzle orifice. An orifice size is configured to increase in response to the flow of air exhaled through the orifice. [00018] In yet another aspect, the respiratory treatment device may comprise a reed positioned adjacent the orifice. The vane can be operatively connected to the limiting element so that it is configured to move the limiting element between the closed position and the open position in response to increased pressure adjacent to the vane. [00019] In another aspect, the variable nozzle is positioned downstream of the limiting element in the exhalation flow path. [00020] In an additional aspect, the orifice of the variable nozzle is substantially rectangular. The orifice of the variable nozzle may remain substantially rectangular after an increase in the size of the orifice in response to the flow of exhaled air through the orifice. [00021] In yet another aspect, a method for performing OPEC therapy includes receiving a flow of exhaled air along a defined exhalation flow path between an inlet and an outlet of a respiratory treatment device, directing the flow of exhaled air towards a reed, and alternate the reed between a first position and a second position in response to the exhaled air flow. The method further includes moving a limiting element in response to the reciprocating movement of the reed between a closed position, in which an exhaled air flow through the chamber inlet is limited, and an open position, in which the exhaled air flow is less limited. [00022] In another aspect, a method for performing OPEC therapy includes receiving an exhaled air flow along a defined exhalation flow path between an inlet and an outlet of a respiratory treatment device, accelerating the exhaled air flow through an orifice positioned along the exhalation flow path, and alternate a vane adjacent to the orifice between a first position and a second position in response to the exhaled air flow through the orifice. The method further includes moving a limiting element in response to the alternating movement of the reed between a closed position, in which an exhaled air flow along the exhalation flow path is limited, and an open position, in which the exhaled air flow along the exhalation flow path is less limited. The method may also include changing an orifice size in response to the flow of air exhaled through the orifice. [00023] In yet another aspect, a respiratory treatment device includes a housing that encloses a plurality of chambers, a first opening in the housing configured to transmit exhaled air into and inhaled air from the housing, a second opening in the housing configured to allow that the air exhaled to the first opening leaves the housing, and a third opening in the housing configured to allow air outside the housing to enter the housing through inhalation at the first opening. An exhalation flow path is defined between the first opening and the second opening, and an inhalation flow path defined between the third opening and the first opening. A limiting element is positioned in the exhalation flow path and inhalation flow path, and is movable between a closed position, in which an air flow along the exhalation flow path or the inhalation flow path is limited , and an open position, in which the flow of exhaled air along the exhalation flow path or inhalation flow path is less limited. A reed is in fluid communication with the exhalation flow path and the inhalation flow path. The vane is operatively connected to the limiting element and configured to alternate between a first position and a second position repeatedly in response to air flow along the exhalation flow path or inhalation flow path. [00024] In an additional aspect, the exhalation flow path and the inhalation flow path form an overlapping part. The air flow along the exhalation flow path and the inhalation flow path along the overlap can be in the same direction. In addition, the limiting element can be positioned on the overlapping part, and the vane can be in fluid communication with the overlapping part. [00025] In another aspect, the limiting element is positioned in a first chamber of the plurality of chambers, and the reed is positioned in a second chamber of the plurality of chambers. The air flow through an inlet to the first chamber can be limited when the limiting element is in the closed position, and the air flow through the inlet can be less limited when the limiting element is in the open position. In addition, the first chamber and the second chamber can be connected through a hole. In addition, the reed can be positioned adjacent to the orifice so that the reed is configured to move the limiting element between the closed position and the open position in response to increased pressure adjacent to the reed. [00026] In yet another aspect, the second opening includes a one-way exhalation valve configured to allow the exhaled air into the housing to exit the housing by means of exhalation at the first opening. [00027] In another aspect, the third opening includes a one-way inhalation valve configured to allow air outside the housing to enter the housing upon inhalation at the first opening. [00028] In an additional aspect, a check valve is positioned along the exhalation flow path between the first opening and the second opening, so that the check valve is configured to open in response to the exhaled air for the first opening, and close in response to inhaled air through the first opening. [00029] In an additional aspect, a check valve is positioned along the path of the inhalation flow between the third opening and the first opening, so that the check valve is configured to open in response to the inhaled air through the first opening, and close in response to the exhaled air for the first opening. [00030] In yet another aspect, the respiratory treatment device may include an inhalation port in fluid communication with a user interface, the inhalation port being adapted to receive a drug suitable for inhalation from a delivery device. aerosol. The aerosol dispensing device can be connected to the inhalation port. [00031] In another aspect, a respiratory treatment device includes a housing that encloses at least one chamber, a first opening chamber, a second opening chamber, a defined flow path between the first opening chamber and the second opening chamber, and a limiting element positioned in the flow path. The limiting element is movable between a closed position, where an air flow along the flow path is limited, and an open position, where the air flow along the flow path is less limited. [00032] In yet another aspect, a respiratory treatment device includes a housing that encloses at least one chamber, a chamber inlet configured to receive exhaled air to at least one chamber, at least one chamber outlet configured to allow the exhaled air exits at least one chamber, and a defined exhalation flow path between the chamber inlet and at least one chamber outlet. A variable nozzle is positioned in the exhalation flow path so that the exhalation flow path passes through a variable nozzle orifice. An orifice size is configured to increase in response to the exhaled airflow through the orifice. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a front perspective view of an OPEC device; Figure 2 is a rear perspective view of the OPEC device of Figure 1; Figure 3 is a perspective cross-sectional view taken along line III in Figure 1 of the OPEC device shown without the internal components of the OPEC device; Figure 4 is an exploded view of the OPEC device of Figure 1, shown with the internal components of the OPEC device; Figure 5 is a cross-sectional perspective view taken along line III in Figure 1 of the OPEC device shown with the internal components of the OPEC device; Figure 6 is a perspective view in different cross-section taken along line VI in Figure 1 of the OPEC device shown with the internal components of the OPEC device; Figure 7 is a view in different cross-sectional perspective taken along line VII in Figure 1 of the OPEC device shown with the internal components of the OPEC device; Figure 8 is a front perspective view of a limiting element operatively connected to a reed; Figure 9 is a rear perspective view of the limiting element operatively connected to the vane shown in Figure 8; Figure 10 is a front view of the limiting element operatively connected to the vane shown in Figure 8; Figure 11 is a top view of the limiting element operatively connected to the reed shown in Figure 8; Figure 12 is a front perspective view of a variable nozzle shown without the exhaled air flow through it; Figure 13 is a rear perspective view of the variable nozzle of Figure 12 shown without the flow of exhaled air through it; Figure 14 is a front perspective view of the variable nozzle of Figure 12 shown with a high flow of exhaled air through Figures 15A to C are phantom top views of the OPEC device of Figure 1 showing an exemplary illustration of the operation of the OPEC device of Figure 1; Figure 16 is a front perspective view of a modality other than a variable nozzle shown without exhaled air flow through it; Figure 17 is a rear perspective view of the variable nozzle in Figure 16 shown without exhaled air flow through; Figure 18 is a front perspective view of a second embodiment of an OPEC device; Figure 19 is a rear perspective view of the OPEC device of Figure 18; Figure 20 is an exploded view of the OPEC device of Figure 18, shown with the internal components of the OPEC device; Figure 21 is a cross-sectional view taken along line I in Figure 18 of the OPEC device, shown with the internal components of the OPEC device; Figure 22 is a cross-sectional view taken from the side line II in Figure 18 of the OPEC device, shown with the internal components of the OPEC device; Figure 23 is a cross-sectional view taken along line III in Figure 18 of the OPEC device, shown with the internal components of the OPEC device; Figure 24 is a front perspective view of an adjustment mechanism of the OPEC device of Figure 18; Figure 25 is a rear perspective view of the adjustment mechanism of Figure 24; Figure 26 is a view front perspective view of a limiting element operatively connected to a reed for use in the OPEC device of Figure 18; Figure 27 is a front perspective view of the adjustment mechanism of Figure 24 assembled with the limiting element and the reed of Figure 26; Figure 28 is a partial cross-sectional view of the set of Figure 27 inside the OPEC device of Figure 18; Figures 29A to B are partial cross-sectional views illustrating the installation of the set of Figu Figure 27 inside the OPEC device of Figure 18; Figure 30 is a front view of the OPEC device of Figure 18 which illustrates an aspect of the adaptability of the OPEC device; Figure 31 is a partial cross-sectional view of the set of Figure 27 inside the OPEC device of Figure 18; Figures 32A to B are partial cross-sectional views taken along line III in Figure 18 of the OPEC device, which illustrate possible configurations of the OPEC device; Figures 33A to B are top phantom views illustrating the adaptability of the OPEC device of Figure 18; Figures 34A to B are top phantom views of the OPEC device of Figure 18, which illustrate the adaptability of the OPEC device; Figure 35 is a view in front view of a third embodiment of an OPEC device; Figure 36 is a cross-sectional view taken along line I in Figure 35 of the OPEC device; Figure 37 is a front perspective view of a adjustment mechanism of the OPEC device of Figure 35 assembled with a limiting element and a reed; Figure 38 is a rear perspective view of the assembly of Figure 37; Figure 39 is a front perspective view of a fourth embodiment of a device of OPEC; Figure 40 is a cross-sectional view taken along line I in Figure 39 of the OPEC device; Figures 41A to B are top phantom views of the OPEC device of Figure 39, which illustrate the adaptability of the device of OPEC; Figure 42 is a front perspective view of an alternative embodiment of the OPEC device of Figure 1; Figure 43 is a cross-sectional view taken along line I in Figure 42 of the OPEC device; Figure 44 is a front perspective view of another alternative embodiment of the OPEC device of Figure 1; Figure 45 is a cross-sectional view taken along line I in Figure 44 of the OPEC device; Figure 46 is a perspective view front view of yet another alternative embodiment of the OPEC device of Figure 1; Figure 47 is a cross-sectional view taken along line I in Figure 46 of the OPEC device; Figure 48 is a front perspective view of another modality of a OPEC device; Figure 49 is a rear perspective view of the OPEC device of Figure 48; Figure 50 is a perspective view of the bottom of the OPEC device of Figure 48; Figure 51 is an exploded view of the OPEC device of Figure 48; Figure 52 is a cross-sectional view taken along line I in Figure 48, shown without the internal components of the OPEC device; Figure 53 is a cross-sectional view taken along line I in Figure 48, shown without the internal components of the OPEC device; Figure 54 is a front perspective view of an internal housing of the OPEC device of Figure 48; Figure 55 is a cross-sectional view of the internal housing taken along the line I in Figure 54; Figure 56 is a perspective view of a reed of the OPEC device of Figure 48; Figure 57 is a front perspective view of a limiting element of the OPEC device of Figure 48; Figure 58 is a Rear perspective view of the limiting element of Figure 57; Figure 59 is a front view of the limiting element of Figure 57; Figure 60 is a front perspective view of an adjustment mechanism of the OPEC device of Figure 48; Figure 61 is a rear perspective view of the adjustment mechanism of Figure 60; Figure 62 is a front perspective view of the adjustment mechanism of Figures 60 to 61, assembled with the limiting element of Figures 57 to 59 and the reed of Figure 56; Figure 63 is a front perspective view of a variable nozzle of the OPEC device of Figure 48; Figure 64 is a rear perspective view of the variable nozzle of Figure 63; Figure 65 is a front perspective view of the check valve of the device OPEC of Figure 48; Figure 66 is a perspective view of another modality of a respiratory treatment device; Figure 67 is an exploded view of the respiratory treatment device of Figure 66; Figure 68 is a cross-sectional perspective view taken along line I in Figure 66 of the respiratory treatment device shown with the internal components of the device; Figure 69 is a perspective cross-sectional view taken along line II in Figure 66 of the respiratory treatment device shown with the components internal device; Figure 70 is a perspective view in different cross-section taken along line I in Figure 66 of the respiratory treatment device, showing part of an exemplary exhalation flow path; Figure 71 is a view in different cross-sectional perspective taken along line II in Figure 66, which shows a part of an exhalation flow path. Figure 72 is another cross-sectional perspective view taken along line I in Figure 66, which shows a part of an exemplary inhalation flow path; Figure 73 is another cross-sectional perspective view taken along line II in Figure 66, which shows part of an exemplary inhalation flow path; Figure 74 is a front perspective view of the OPEC device of Figure 48, connected with an exemplary aerosol dispensing device in the form of a nebulizer. DETAILED DESCRIPTION [00033] OPEC therapy is effective within a range of operating conditions. For example, an adult human can have an exhalation flow rate in the range of 10 to 60 liters per minute, and can maintain a static exhalation pressure in the range of 8 to 18 cm H2O. Within these parameters, OPEC therapy is believed to be the most effective when changes in exhalation pressure (ie, amplitude) are in the range of 5 to 20 cm H2O, oscillating at a frequency of 10 to 40 Hz. In contrast, a teenager may have a much lower exhalation flow rate, and may maintain a lower static exhalation pressure, thereby changing the most effective operating conditions for administering OPEC therapy. Likewise, the ideal operating conditions for someone suffering from a respiratory illness, or in contrast, a healthy athlete, may differ from those of an average adult. As described below, the components of the OPEC devices described are selectable and / or adjustable so that the ideal operating conditions (for example, range and frequency of oscillating pressure) can be identified and maintained. Each of the various modalities described in this document reach the frequency and amplitude ranges that are within the desired ranges presented above. Each of the various modalities described in this document can also be configured to reach frequencies and amplitudes that are outside the ranges presented above. FIRST MODE [00034] Referring first to Figures 1 to 4, a front perspective view, a rear perspective view, a front perspective view in cross section, and an exploded view of an OPEC 100 device are shown. For purposes of illustration, the internal components of the OPEC device 100 are omitted in Figure 3. The OPEC device 100 generally comprises a housing 102, a chamber inlet 104, a first chamber outlet 106, a second chamber outlet 108 ( best seen in Figures 2 and 7), and a nozzle 109 in fluid communication with chamber inlet 104. Although nozzle 109 is shown in Figures 1 to 4 as being integrally formed with housing 102, the nozzle is provided 109 can be removable and replaceable with a nozzle 109 of a different size or shape, as required to maintain optimal operating conditions. In general, housing 102 and nozzle 109 can be produced from any durable material, such as a polymer. Such material is Polypropylene. Alternatively, acrylonitrile butadiene styrene (ABS) can be used. [00035] Alternatively, other or additional interfaces, such as breathing tubes or gas masks (not shown) can be attached in fluid communication with the nozzle 109 and / or associated with housing 102. For example, housing 102 may include a inhalation port (not shown) that has a separate one-way inhalation valve (not shown) in fluid communication with nozzle 109 to allow a user of the OPEC 100 device to inhale the surrounding air through the check valve and exhale through chamber inlet 104 without removing nozzle 109 from the OPEC device 100 between periods of inhalation and exhalation. In addition, any number of aerosol dispensing devices can be connected to the OPEC device 100, for example, via the inhalation port mentioned above, for simultaneous administration of aerosol and OPEC therapies. As such, the inhalation port may include, for example, an elastomeric adapter, or other flexible adapter, capable of accommodating the different nozzles or outlets of the particular aerosol dispensing device that a user intends to use with the OPEC 100 device. used in this document, the term aerosol delivery devices is to be understood to include, for example, without limitation, any nebulizer, soft mist inhaler, pressurized metered dose inhaler, dry powder inhaler, combination of a holding chamber and pressurized metered dose inhaler or the like. Suitable commercially available aerosol dispensing devices include, without limitation, the AEROECLIPSE nebulizer, RESPIMAT soft mist inhaler, LC Sprint nebulizer, AEROCHAMBER PLUS retention chambers, MICRO MIST nebulizers, SIDESTREAM nebulizers, Inspiration Elite nebulizers, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL, pMDI FLOVENTOL. , pMDI BECLOVENT, pMDI QVAR and PMDI AEROBID, pMDI XOPENEX, pMDI PROAIR, pMDI PROVENT, pMDI SYMBICORT, DPI TURBOHALER and DPI DISKHALER. Descriptions of suitable aerosol delivery devices include, without limitation, aerosol delivery devices found in U.S. Patents 4,566,452; 5,012,803; 5,012,804; 5,312,046; 5,497,944; 5,622,162; 5,823,179; 6,293,279; 6,435,177; 6,484,717; 6,848,443; 7,360,537; 7,568,480; and 7,905,228, which are fully incorporated by reference in this document. [00036] In Figures 1 to 4, housing 102 is generally box-shaped. However, a housing 102 of any shape can be used. In addition, chamber inlet 104, first chamber outlet 106 and second chamber outlet 108 can be of any shape or series of shapes, such as a plurality (i.e., more than one) of circular passages or linear notches. More importantly, it should be understood that the cross-sectional area of the chamber inlet 104, the first chamber outlet 106 and the second chamber outlet 08 are just some of the factors that influence the ideal operating conditions described above. [00037] Preferably, housing 102 is capable of being opened so that the components contained therein can be periodically accessed, cleaned, replaced or reconfigured, as required to maintain the ideal operating conditions. As such, housing 102 is shown in Figures 1 to 4 as comprising a front section 101, a middle section 103, and a rear section 105. The front section 101, the middle section 103 and the rear section 105 can be connected removably from each other by any suitable means, such as a pressure fitting, a compression fitting, etc., so that a seal is formed between the relative sections sufficiently to allow the OPEC 100 device to properly administer the therapy by OPEC. [00038] As shown in Figure 3, an exhalation flow path 110, identified by a dashed line, is defined between the nozzle 109 and at least one of the first chamber outlet 06 and the second chamber outlet 108 (best seen) in Figure 7). More specifically, the exhalation flow path 110 begins at nozzle 109, passes through chamber inlet 104, and enters a first chamber 114, or an inlet chamber. In the first chamber 114, the exhalation flow path turns 180 degrees, passes through a chamber passage 16, and enters a second chamber 18, or an exit chamber. In the second chamber 118, the exhalation flow path 110 can exit the OPEC device 100 through at least one of the first chamber outlet 106 and the second chamber outlet 108. Thus, the exhalation flow path 110 is "folded" over itself, that is, it reverses the longitudinal directions between the chamber inlet 104 and one of the first chamber outlet 06 or the second chamber outlet 108. However, those skilled in the art will understand that the flow path exhalation 110 identified by the dashed line is exemplary, and that the air exhaled to the OPEC device 100 can flow in any number of directions or paths as it travels from nozzle 109 or chamber inlet 104 and to the first chamber outlet 106 or the second chamber outlet 108. [00039] Figure 3 also shows several other attributes of the OPEC device 100 associated with housing 102. For example, a lock 122 prevents a limiting element 130 (see Figure 5), described below, from opening in the wrong direction; a seat 124 shaped to accommodate the limiting element 130 is formed around the chamber inlet 104; and, an upper support 126 and a lower support 128 are formed within the housing 102 and configured to accommodate a rotatable mounted axis therebetween. One or more guide walls 120 are positioned in the second chamber 118 to direct the exhaled air along the exhalation flow path 110. [00040] Turning to Figures 5 to 7, several cross-sectional perspective views of the OPEC 100 device are shown with its internal components. The internal components of the OPEC device 100 comprise a limiting element 130, a reed 132, and an optional variable nozzle 136. As shown, the limiting element 130 and reed 132 are operatively connected via an axis 134 pivotally mounted between the upper support 126 and lower support 128, so that the limiting element 130 and the reed 132 are rotatable synchronously around the axis 134. As described in more detail below, the variable nozzle 136 includes an orifice 138 configured to increase in size by response to the flow of exhaled air through it. [00041] Figures 4 to 6 further illustrate the division of the first chamber 114 and the second chamber 118 into the housing 102. As previously described, the chamber inlet 104 defines an entrance to the first chamber 114. The limiting element 130 is positioned in the first chamber 114 relative to a seat 124 around the chamber inlet 104, so that it is movable between a closed position, in which an exhaled air flow along the exhalation flow path 110 through the chamber inlet 104 is limited, and an open position, in which the air flow exhaled through chamber inlet 104 is less limited. Likewise, the variable nozzle 136, which is optional, is mounted around or positioned in the chamber passage 116, so that the exhaled air flow entering the first chamber 114 exits the first chamber 114 through the orifice 138 of the variable nozzle 136. The exhaled air that exits the first chamber 114 through orifice 138 of the variable nozzle 136 enters the second chamber, which is defined by the space inside the housing 102 occupied by the reed 132 and the guide walls 120. Depending on the position of the reed 132, the exhaled air is then able to exit the second chamber 118 through at least one of the first chamber outlet 106 and the second chamber outlet 108. [00042] Figures 8 to 14 show the internal components of the OPEC 100 device in greater detail. Turning first to Figures 8 to 9, a front perspective view and a rear perspective view show the limiting element 130 operatively connected to the vane 132 by the axis 134. As such, the limiting element 130 and the vane 132 are rotatable to the around the axis 34 so that the rotation of the limiting element 130 results in a corresponding rotation of the reed 132, and vice versa. Like housing 102, limiting element 130 and reed 132 can be produced from any durable material, such as a polymer. Preferably, they are produced from a low friction, low shrinkage plastic. Such material is acetal. [00043] As shown, the limiting element 130, the reed 132, and the axis 134 are formed as a unitary component. The limiting element 130 is generally disk-shaped, and the reed 132 is flat. The limiting element 30 includes a generally circular face 140 axially displaced from the axis 134 and an oblique or chamfered edge 142 shaped to engage the seat 124 formed around the chamber inlet 104. In this way, the limiting element 30 is adapted to move in with respect to the chamber inlet 104 about an axis of rotation defined by the axis 134, so that the limiting element 130 can engage the seat 124 in a closed position to substantially seal and limit the flow of exhaled air through the chamber inlet 104. However, it is envisaged that the limiting element 130 and the reed 132 can be formed as separate components connectable by any suitable means, so that they remain independently replaceable by a limiting element 130 or a reed 132 of a different shape, size or weight, as selected to maintain optimal operating conditions. For example, the limiting element 130 and / or the reed 32 can include one or more contoured surfaces. Alternatively, the limiting element 130 can be configured as a butterfly valve. [00044] Turning to Figure 10, a front view of the limiting element 130 and the reed 132 is shown. As previously described, the limiting element 130 comprises a generally circular face 140 axially displaced from the axis 134. The limiting element 130 further comprises a second misalignment designed to facilitate the movement of the limiting element 130 between a closed position and an open position. More specifically, a center 144 of the face 140 of the limiting element 30 is offset from the plane defined by the radial misalignment and the axis 134, or the geometric axis of rotation. In other words, a larger surface area of the face 140 of the limiting element 130 is positioned on one side of the axis 34 than on the other side of the axis 134. The pressure in the chamber inlet 104 derived from exhaled air produces a force acting on the face 140 of the limiting element 130. As the center 144 of face 140 of the limiting element 130 is displaced, as described above, a resulting force differential creates torque around axis 134. As further explained below, this torque facilitates the movement of the limiting element 130 between a closed position and an open position. [00045] Turning to Figure 11, a top view of the limiting element 130 and the reed 132 is shown. As shown, vane 132 is connected to axis 134 at an angle of 75 ° to face 140 of limiting element 130. Preferably, the angle will remain between 60 ° and 80 °, although it is anticipated that the angle of vane 132 can be selectively adjusted to maintain ideal operating conditions, as previously discussed. It is also preferable that the reed 132 and the limiting element 130 are configured so that, when the OPEC device 100 is fully assembled, the angle between a center line of the variable nozzle 136 and the reed 132 is between 10 ° and 25 ° when the limiting element 130 is in a closed position. In addition, regardless of the configuration, it is preferable that the combination of the limiting element 130 and the reed 132 has a center of gravity aligned with the axis 134, or the geometric axis of rotation. With full view of the present description, it should be apparent to those skilled in the art that the angle of the reed 32 can be limited by the size or shape of the housing 102, and will generally be less than half the total rotation of the reed 132 and the limiting element 130. [00046] Turning to Figures 12 and 13, a front perspective view and a rear perspective view of the variable nozzle 136, this is shown without the exhaled air flow through it. In general, the variable nozzle 136 includes top and bottom walls 146, side walls 148, and V-shaped slits 150 formed between them. As shown, the variable nozzle is generally shaped like a duckbill valve. However, it should be understood that nozzles or valves of other shapes and sizes can also be used. The variable nozzle 136 can also include a flange 52 configured to mount the variable nozzle 136 within the housing 102 between the first chamber 114 and the second chamber 118. The variable nozzle 136 can be produced or molded from any material that has a flexibility suitable, such as silicone, and preferably with a wall thickness between 0.50 and 2.00 mm, and an orifice width between 0.25 to 1.00 mm, or less depending on manufacturing capabilities. [00047] As previously described, the variable nozzle 136 is optional in the operation of the OPEC 100 device. It should also be understood that the OPEC 100 device could alternatively omit the chamber passage 116 and the variable nozzle 136, and thus comprise a modality single chamber. Although functional without the variable nozzle 136, the performance of the OPEC 100 device over a wider range of exhalation flow rates is enhanced when the OPEC 100 device is operated with the variable nozzle 136. The chamber passage 116, when used without variable nozzle 136, or orifice 138 of variable nozzle 136, when variable nozzle 136 is included, serves to create a jet of exhaled air that has an increased speed. As explained in greater detail below, the increased velocity of exhaled air entering the second chamber 118 results in a proportional increase in the force applied by the exhaled air to the vane 132 and, in turn, greater torque around axis 134, in that all affect optimal operating conditions. [00048] Without the variable nozzle 136, the hole between the first chamber 114 and the second chamber 118 is fixed according to the size, shape, and cross-sectional area of the chamber passage 116, which can be selectively adjusted by any means replacement of the middle section 103 or the rear section 105 of the housing. On the other hand, when the variable nozzle 136 is included in the OPEC device 100, the orifice between the first chamber 114 and the second chamber 118 is defined by the size, shape, and cross-sectional area of the orifice 138 of the variable nozzle 136, which it can vary according to the rate of exhaled air flow and / or the pressure in the first chamber 114. [00049] Turning to Figure 14, a front perspective view of the variable nozzle 136 is shown with an exhaled air flow through it. An aspect of the variable nozzle 36 shown in Figure 14 is that as orifice 138 opens in response to the flow of exhaled air through it, the cross-sectional shape of orifice 138 remains generally rectangular, which during OPEC therapy administration results in a lower pressure drop through the variable nozzle 136 from the first chamber 114 (See Figures 3 and 5) to the second chamber 118. The generally consistent rectangular shape of the orifice 138 of the variable nozzle 136 during higher flow rates is reached by the V-shaped slits 150 formed between the top and bottom walls 146 and the side walls 148, which serves to allow the side walls 148 to flex without restriction. Preferably, the V 150-shaped slits are as thin as possible to minimize leakage of exhaled air through them. For example, the V 150-shaped slots may be approximately 0.25 mm wide, but depending on manufacturing capabilities, it could be in the range of 0.10 to 0.50 mm. The exhaled air that leaks through the V-shaped slits 150 is finally directed along the exhalation flow path through the guide walls 120 in the second chamber 118 projecting from the housing 102. [00050] It should be understood that numerous factors contribute to the impact that the variable nozzle 136 has on the performance of the OPEC 100 device, including the geometry and material of the variable nozzle 136. For the purposes of example only, in order to obtain a frequency oscillating target pressure between 10 to 13 Hz at an exhalation flow rate of 15 liters per minute, in one embodiment, a 1.0 by 20.0 millimeter passage or orifice can be used. However, as the exhalation flow rate increases, the frequency of the oscillating pressure in that mode also increases, albeit at a very fast rate compared to the target frequency. In order to obtain a target pressure oscillating frequency between 18 to 20 Hz at an exhalation flow rate of 45 liters per minute, the same modality can use a 3.0 x 20.0 mm passage or orifice. This relationship shows that a passage or orifice that expands in an area in cross section is desirable as the exhalation flow rate increases in order to limit the pressure drop through the variable nozzle 136. [00051] Turning to Figures 15A to C, top ghost views of the OPEC 100 device show an exemplary illustration of the operation of the OPEC 100 device. Specifically, Figure 15A shows the limiting element 130 in an initial position, or closed, in which the flow of exhaled air through the chamber inlet 104 is limited, and the reed 132 is in a first position, which directs the flow of exhaled air towards the first chamber outlet 106. Figure 15B shows this element limiter 130 in a partially open position, where the flow of exhaled air through chamber inlet 104 is less limited, and the vane 132 is directly aligned with the exhaled air jet exiting the variable nozzle 136. Figure 15C shows the limiting element 130 in an open position, where the flow of exhaled air through the chamber inlet 104 is even less limited, and the reed 132 is in a second position, which directs the flow of exhaled air towards the second chamber outlet. 108 It should be understood that the cycle described below is merely an example of the operation of the OPEC 100 device, and that numerous factors can affect the operation of the OPEC 100 device in a way that results in a deviation from the described cycle. However, during the operation of the OPEC device 100, the limiting element 130 and the reed 132 will generally alternate between the positions shown in Figures 5A and 15C. [00052] During the administration of OPEC therapy, the limiting element 130 and the reed 132 can be initially positioned as shown in Figure 15A. In that position, the limiting element 130 is in a closed position, in which the flow of exhaled air along the exhalation path through the chamber inlet 104 is substantially limited. As such, an exhalation pressure at chamber inlet 04 begins to increase when a user exhales at nozzle 108. As the exhalation pressure at chamber inlet 104 increases, a corresponding force acting on face 140 of limiting element 130 increases. As previously explained, as the center 144 of face 140 is displaced from the plane defined by radial misalignment and axis 34, a resulting net force creates a negative or opening torque around the axis. In turn, the opening torque tilts the limiting element 130 to rotate and open, allowing the exhaled air to enter the first chamber 114, and tilts the vane 132 away from its first position. As the limiting element 30 opens and exhaled air is allowed to enter the first chamber 114, the pressure at the chamber inlet 104 begins to decrease, the force acting on face 140 of the limiting element begins to decrease, and the torque that tilts the element limiter 130 to open starts to decrease. [00053] As the exhaled air continues to enter the first chamber 114 through the chamber inlet 104, it is directed along the exhalation flow path 110 through the housing 102 until reaching the chamber passage 116 arranged between the first chamber 114 and the second chamber 118. If the OPEC device 100 is being operated without the variable nozzle 136, the exhaled air accelerates through the chamber passage 116 due to the decrease in the cross-sectional area to form a jet of exhaled air. Likewise, if the OPEC device 100 is being operated with variable nozzle 136, the exhaled air accelerates through orifice 138 of variable nozzle 136, where pressure through orifice 138 causes the side walls 148 of the variable nozzle 136 flex outward, thus increasing the size of the orifice 138, as well as the resulting flow of exhaled air through it. To the extent that a little exhaled air leaks out of the V 150-shaped slits of the variable nozzle 136, it is directed back towards the jet of exhaled air and along the exhalation flow path through the guide walls. 120 that are designed for housing 102. [00054] Then, as the exhaled air leaves the first chamber 114 through the variable nozzle 136 and / or passage of chamber 116 and enters the second chamber 118, it is directed by the reed 132 towards the front section 101 of the housing 102, where it is forced to reverse directions before exiting the OPEC device 100 through the outlet of the first open chamber 106. As a result of the change in the direction of the exhaled air towards the front section 101 of housing 102, pressure builds up in the second chamber 118 close to the front section 101 of housing 02, thus resulting in a force on the adjacent vane 132, and creating an additional negative or opening torque around axis 134. The combined opening torques created around axis 134 from forces acting on face 140 of limiting element 130 and vane 132 cause the limiting element 130 and vane 132 to rotate around axis 134 from the position shown in Figure 15A towards the position shown in Figure 15B. [00055] When the limiting element 130 and the vane 132 rotate to the position shown in Figure 15B, the vane 132 crosses the jet of exhaled air leaving the variable nozzle 136 or the chamber passage 6. Initially, the jet of exhaled air exiting the variable nozzle 136 or chamber passage 116 provides a force on the reed 132 which, together with the momentum of the reed 132, the axis 134 and the limiting element 130, pushes the reed 132 and the limiting element 130 to the position shown in Figure 15C. However, around the position shown in Figure 15B, the force acting on the vane 132 of the exhaled air exiting the variable nozzle 136 also switches from a negative or opening torque to a positive or closing torque. More specifically, as the exhaled air leaves the first chamber 114 through the variable nozzle 136 and enters the second chamber 118, it is directed by the reed 132 towards the front section 101 of the housing 102, where it is forced to reverse directions before exit the OPEC device 100 via the second open chamber outlet 108. As a result of the change in the direction of the exhaled air towards the front section 101 of the housing 102, pressure builds up in the second chamber 118 next to the front section 101 of the housing 102, thus resulting in a force on the adjacent vane 132, and creating a positive or closing torque around axis 134. As the vane 132 and the limiting element 130 continue to move closer to the position shown in Figure 15C, the pressure which accumulates in the chamber of section 118 next to the front section 101 of the housing 102 and, in turn, the positive or closing torque around the axis 134, continues to increase, according to the air flow exhaled along of the exhalation flow path 110 and through the chamber inlet 104 is even less limited. Meanwhile, although the torque around axis 134 of the force acting on the limiting element 130 also switches from a negative or opening torque to a positive or closing torque around the position shown in Figure 15B, its magnitude is essentially insignificant as the limiting element 130 and the reed 132 rotate from the position shown in Figure 15B to the position shown in Figure 15C. [00056] After reaching the position shown in Figure 15C, and due to the higher positive or closing torque around axis 134, the reed 132 and the limiting element 130 reverse directions and begin to rotate back towards the position shown in Figure 5B. As the reed 132 and the limiting element 130 approach the position shown in Figure 15B, and the exhaled flow through the chamber inlet 104 is increasingly limited, the positive or closing torque around axis 134 begins to decrease. When the limiting element 130 and the vane 132 reach the position 130 shown in Figure 5B, the vane 132 crosses the jet of exhaled air exiting the variable nozzle 136 or the chamber passage 116, thus creating a force in the vane 132 that , together with the momentum of the reed 132, the axis 134 and the limiting element 130, propels the reed 132 and the limiting element 130 back to the position shown in Figure 15A. After the limiting element 130 and the vane 132 return to the position shown in Figure 15A, the flow of exhaled air through the chamber inlet 104 is limited, and the cycle described above is repeated. [00057] It should be understood that, during a single exhalation period, the cycle described above will repeat numerous times. Thus, by repeatedly moving the limiting element 130 between a closed position, where the flow of exhaled air through the chamber inlet 104 is limited, and an open position, where the air exhaled through the chamber inlet 104 is less limited, oscillating counter pressure is transmitted to the user of the OPEC 100 device and OPEC therapy is administered. [00058] Turning now to Figures 16 to 7, an alternative embodiment of a variable nozzle 236 is shown. The variable nozzle 236 can be used in the OPEC device 100 as an alternative to the variable nozzle 136 described above. As shown in Figures 16 to 17, the variable nozzle 236 includes an orifice 238, top and bottom walls 246, side walls 248 and a flange 252 configured to mount the variable nozzle 236 within the housing of the OPEC device 100 between the first chamber 114 and second chamber 118 in the same manner as variable nozzle 136. Similar to variable nozzle 136 shown in Figures 12 to 13, variable nozzle 236 can be produced or molded from any material that has adequate flexibility, such as silicone . [00059] During OPEC therapy administration, as orifice 238 of variable nozzle 236 opens in response to the flow of exhaled air through it, the cross-sectional shape of orifice 238 remains generally rectangular, resulting in a drop lower pressure through the variable nozzle 236 from the first chamber 114 to the second chamber 118. The generally consistent rectangular shape of the orifice 238 of the variable nozzle 236 during higher flow rates is achieved by wrinkled and thin walls formed in the top and bottom walls 246, which allows the side walls 248 to flex more easily and with less resistance. An additional advantage of this modality is that there is no leakage out of the top and bottom walls 246 as the exhaled air flows through the orifice 238 of the variable nozzle 236, such as, for example, through the V-shaped slits of the variable nozzle 150 136 shown in Figures 12 to 13. [00060] Those skilled in the art will also understand that, in some applications, only positive expiratory pressure (without oscillation) may be desired, in which case the OPEC 100 device can be operated without the limiting element 130, but with a fixed orifice or manually adjustable orifice instead. The positive expiratory pressure mode can also comprise the variable nozzle 136, or the variable nozzle 236, in order to maintain a relatively consistent back pressure within a desired range. SECOND MODE [00061] Turning now to Figures 18 to 19, a front perspective view and a rear perspective view of a second embodiment of an OPEC device 200 is shown. The configuration and operation of the OPEP 200 device is similar to that of the OPEP 100 device. However, as best shown in Figures 20 to 24, the OPEP 200 device also includes an adjustment mechanism 253 adapted to change the relative position of the inlet. of chamber 204 in relation to housing 202 and limiting element 230 which, in turn, changes the rotation range of the vane 232 operatively connected thereto. As explained below, a user is therefore able to conveniently adjust the frequency and amplitude of OPEC therapy administered by the OPEC device 200 without opening housing 202 and disassembling the components of the OPEC device 200. [00062] The OPEC device 200 generally comprises a housing 202, a chamber inlet 204, a first chamber outlet 206 (best seen in Figures 23 and 32), a second chamber outlet 208 (best seen in Figures 23 and 32), and a nozzle 209 in fluid communication with the chamber inlet 204. As with the OPEC device 100, a front section 201, a middle section 203, and a rear section 205 of housing 202 are separable, so that the components contained therein can be periodically accessed, cleaned, replaced, or reconfigured, as required to maintain optimal operating conditions. The OPEC device also includes an adjustment dial 254, as described below. [00063] As discussed above in relation to the OPEC 100 device, the OPEC 200 device can be adapted for use with other or additional interfaces, such as an aerosol dispensing device. In that regard, the OPEC device 200 is equipped with an inhalation port 211 (best seen in Figures 19, 21, and 23) in fluid communication with nozzle 209 and chamber inlet 204. As noted above, the inlet port inhalation may include a separate check valve (not shown) to allow a user of the OPEC 200 device to inhale the surrounding air through the check valve and exhale through chamber inlet 204 without removing the nozzle 209 of the OPEC 200 device between inhalation and exhalation periods. In addition, the aerosol delivery devices previously mentioned can be connected to the inhalation port 211 for simultaneous administration of aerosol and OPEC therapies. [00064] An exploded view of the OPEC device 200 is shown in Figure 20. In addition to the housing components described above, the OPEC device 200 includes a limiting element 230 operatively connected to a reed 232 by a pin 231, an adjustment mechanism 253, and a variable nozzle 236. As shown in the cross-sectional view of Figure 21, when the OPEC device 200 is in use, the variable nozzle 236 is positioned between the middle section 203 and the rear section 205 of housing 202, and the adjustment mechanism 253, the limiting element 230, and the reed 232 form an assembly. [00065] Turning to Figures 21 to 23, several cross-sectional perspective views of the OPEC 200 device are shown. As with the OPEP 100 device, an exhalation flow path 210, identified by a dashed line, is defined between nozzle 209 and at least one of the first chamber outlet 206 and the second chamber outlet 208 (best seen in the Figures 23 and 32). As a result of a check valve (not shown) and / or an aerosol dispensing device (not shown) attached to the inhalation port 211, the exhalation flow path 210 begins at nozzle 209 and is directed towards the chamber inlet 204, which in operation may or may not be blocked by the limiting element 230. After passing through the chamber inlet 204, the exhalation flow path 210 enters a first chamber 214 and makes a 180 ° turn towards the variable nozzle 236. After passing through orifice 238 of variable nozzle 236, the exhalation flow path 210 enters a second chamber 218.In the second chamber 218, exhalation flow path 210 may exit the OPEC device 200 through at least one of the first chamber exit 206 or second chamber exit 208. Those skilled in the art will understand that the exhalation flow path 210 identified by the dashed line is exemplary, and that the exhaled air to the OPEC device 200 may flow in any number of directions or paths as it travels from nozzle 209 or chamber inlet 204 to the first chamber outlet 206 or the second chamber outlet 208. [00066] Referring to Figures 24 to 25, the front and rear perspective views of the adjustment mechanism 253 of the OPEC device 200 are shown. In general, the adjustment mechanism 253 includes an adjustment dial 254, an axis 255, and a frame 256. A protrusion 258 is positioned on a rear face 260 of the adjustment dial, and is adapted to limit the selective rotation of the adjustment mechanism. 253 by a user, as further described below. Axis 255 includes keyed portions 262 adapted to fit within upper and lower supports 226, 228 formed in housing 200 (see Figures 21 and 28 to 29). The shaft also includes an axial bore 264 configured to receive the pin 231 that operationally connects the limiting element 230 and the vane 232. As shown, the frame 256 is spherical, as explained below, it is configured to rotate in relation to the housing 202 , while forming a seal between housing 202 and frame 256 sufficient to allow delivery of therapy by OPEC. The frame 256 includes a circular opening defined by a seat 224, adapted to accommodate the limiting element 230. In use, the circular opening functions as the chamber entrance 204. The frame256 also includes a lock 222 to prevent the limiting element 230 from opening in a wrong direction. [00067] Turning to Figure 26, a front perspective view of the limiting element 230 and the reed 232 is shown. The design, materials and configuration of the limiting element 230 and the reed 232 can be the same as described above in relation to the OPEP100 device. Meanwhile, the limiting element 230 and the reed 232 in the OPEP device 200 are operatively connected by a pin 231 adapted for insertion through the axial hole 264 in the axis 255 of the adjustment mechanism 253. The pin 231 can be produced, for example, by stainless steel. Thus, the rotation of the limiting element 230 results in a corresponding rotation of the reed 232, and vice versa. [00068] Turning to Figure 27, a front perspective view of the adjustment mechanism 253 mounted as a limiting element 230 and the reed 232 is shown. In this configuration, it can be seen that the limiting element 230 is positioned so that it is rotatable with respect to frame 256 and seat 224 between a closed position (as shown), in which an exhaled air flow along the exhalation flow path 210 through chamber inlet 204 is limited, and an open position (not shown), in which the flow of exhaled air through chamber inlet 204 is less limited. As previously mentioned, vane 232 is operatively connected to the limiting element 230 by pin 231 extending through axis 255, and is adapted to move synchronously with the limiting element 230. It can also be seen that the limiting element 230 and the vane 232 are supported by adjustment mechanism 253, which is itself rotatable within housing 202 of the OPEC device 200, as explained below. [00069] Figures 28 and 29A to B are partial cross-sectional views illustrating the adjustment mechanism 253 mounted inside the housing 202 of the OPEC device 200. As shown in Figure 28, the adjustment mechanism 253, as well as the element stop 230 and vane 232, are pivotally mounted within housing 200 around an upper and lower support 226, 228, so that a user is able to rotate the adjustment mechanism253 using the adjustment dial 254. The Figures 29A to 29B further illustrate the assembly and locking process of the adjustment mechanism 253 within the lower support 228 of the housing 202. More specifically, the keyed portion 262 of the shaft 255 is aligned with and inserted through a rotational lock 166 formed in the housing 202, as shown shown in Figure 29A. Once the keyed portion 262 of shaft 255 is inserted through rotational lock 266, shaft 255 is rotated 90 ° to a locked position, but remains free to rotate. Adjustment mechanism 253 is mounted and locked within the upper support 226 in the same manner. [00070] Once the housing 200 and the internal components of the OPEP device 200 are assembled, the rotation of the shaft 255 is limited to keep it within a locked position on the rotational lock 166. As shown in a front view of the device of OPEP 200 in Figure 30, two locks 268, 288 are positioned in housing 202 so that they engage protrusion 258 formed on the rear face 260 of the adjustment dial 254 when a user rotates the adjustment dial 254 to a predetermined position. For purposes of illustration, the OPEC device 200 is shown in Figure 30 without the adjustment dial 254 or the adjustment mechanism 253, which would extend from housing 202 through an opening 269. Thus, the rotation of the adjustment dial 254 , the adjustment mechanism 253 and the keyed portion 262 of the shaft 255 can be suitably limited. [00071] Turning to Figure 31, a partial cross-sectional view of the adjustment mechanism 253 mounted inside the housing 200 is shown. As previously mentioned, the frame 256 of the adjustment mechanism 253 is spherical, and is configured to rotate with respect to the housing 202, while forming a seal between the housing 202 and the frame 256, sufficient to allow the administration of OPEC therapy. As shown in Figure 31, a flexible cylinder 271 extending from housing 202 completely surrounds part of the frame 256 to form a sealing edge 270. As well as the housing 202 and the limiting element 230, the flexible cylinder 271 and the frame 256 can be produced from a low friction, low shrinkage plastic. Such material is acetal. In this way, the sealing edge 270 contacts the frame 256 for a complete 360 ° turn and forms a seal for the entire permissible rotation of the adjustment element 253. [00072] The selective adjustment of the OPEC 200 device will now be described with reference to Figures 32A to B, 33A to B, and 34A to B. Figures 32A to B are partial cross-sectional views of the OPEC 200 device; Figures 33A to B are illustrations of the adaptability of the OPEC 200 device; and Figures 34A to B are top phantom views of the OPEC device 200. As previously mentioned in relation to the OPEC device 100, it is preferable that the reed 232 and the limiting element 230 are configured so that, when the OPEC device 200 is completely assembled, the angle between the center line of the variable nozzle 236 and the reed 232 is between 10 ° and 25 ° when the limiting element 230 is in a closed position. However, it should be understood that the adaptability of the OPEC 200 device is not limited to the parameters described in this document, and that any number of configurations can be selected for the purpose of administering OPEC therapy under optimal operating conditions. [00073] Figure 32A shows the reed 232 at an angle of 10 ° from the center line of the variable nozzle 236, while Figure 32B shows the reed 232 at an angle of 25 ° from the center line of the variable nozzle 236. Figure 33A illustrates necessary positioning of the frame 256 (shown in dotted lines) in relation to the variable nozzle 236 so that the angle between a center line of the variable nozzle 236 and the reed 232 is 10 ° when the limiting element 230 is in the closed position. Figure 33B, on the other hand, illustrates the required position of the frame 256 (shown in dotted lines) in relation to the variable nozzle 236 so that the angle between a center line of the variable nozzle 236 and the reed 232 is 25 ° when the limiting element 230 is in the closed position. [00074] Referring to Figures 34A to B, the side phantom views of the OPEC 200 device are shown. The configuration shown in Figure 34A corresponds to the illustrations shown in Figures 32A and 33A, the angle between a center line of the variable nozzle 236 and the reed 232 being 10 ° when the limiting element 230 is in the closed position. Figure 34B, on the other hand, corresponds to the illustrations shown in Figures 32B and 33B, the angle between a center line of the variable nozzle 236 and the shroud 232 being 25 ° when the limiting element 230 is in the closed position. In other words, the frame 256 of the adjustment element 253 is rotated counterclockwise 15 °, from the position shown in Figure 34A to the position shown in Figure 34B, thereby also increasing the permissible rotation of the reed 232. [00075] In this way, a user is able to rotate the adjustment dial 254 to selectively adjust the orientation of camera input 204 with respect to limiter element 230 and housing 202. For example, a user can increase the frequency and amplitude of therapy by OPEC administered by the OPEC device 200 by turning the adjustment dial 254 and, therefore, the frame 256 towards the position shown in Figure 34A. Alternatively, a user can decrease the frequency and amplitude of OPEC therapy delivered by the OPEC device 200 by rotating the adjustment dial 254 and, therefore, the frame 256 towards the position shown in Figure 34B. Additionally, as shown, for example, in Figures 18 and 30, evidence can be provided to assist the user in defining the appropriate configuration of the OPEP 200 device. [00076] Operating conditions similar to those described below with reference to the OPEC device 800 can also be realized for an OPEC device according to the OPEC device 200. THIRD MODE [00077] Turning now to Figures 35 to 38, a third embodiment of an OPEC 300 device is shown. As described below, with the exception of a 353 adjustment mechanism, the design and operation of the OPEP 300 device is the same as that of the OPEP 200 device. For example, as seen in the front perspective view of Figure 35, a housing 302 of the OPEC device 300 includes a nozzle 309, a first chamber outlet 306, and a second chamber outlet (not shown) positioned opposite the first chamber outlet 306. Housing 302 is formed by a front section 301, a section of middle 303, and a rear section 305. As shown in the cross-sectional view of Figure 36, the OPEC device 300 also includes a stop member 330 operatively connected to a reed 332 by an axis (not shown), and a variable nozzle 336 separating a first chamber 314 and a second chamber 318. Finally, an exhalation flow path 310, identified by a dashed line, is formed between the nozzle 309 and at least one of the first chamber outlet 306 and the second camera output. Those skilled in the art will understand that the exhalation flow path 310 identified by the dashed line is exemplary, and that the exhaled air to the OPEC 300 device can flow in any number of directions or paths as it travels through the 309 nozzle or inlet. chamber 304 for the first chamber outlet 306 or the second chamber outlet. [00078] Referring to Figures 37 to 38, a front perspective view and a rear perspective view of the adjustment mechanism 353 mounted with the limiting element 330 and the reed 332 are shown. The adjustment mechanism 353 is comprised of a bowl 372 formatted to fit within the housing 302 so that a user can rotate the bowl 372 relative to the housing 302 by means of an adjustment dial 354. A wall 374 extends through the part center of bowl 372. Wall 372 includes an opening defined by a seat 324 shaped to accommodate the limiting element 330. As seen in Figure 36, the opening operates as the chamber entrance 304 during OPEC therapy delivery. The bowl 372 further includes an upper support 326 and a lower support 328 adapted to swivel the limiting element 330, the reed 332, and the shaft (not shown) to the adjusting mechanism 353, so that the limiting element 330 and the reed 332 is rotatable in relation to the bowl 372. The wall also includes a lock 322 to prevent the limiting element330 from opening in the wrong direction. [00079] When the OPEC device 300 is fully assembled, as shown in Figures 35 to 36, a user is able to rotate the adjustment dial 354 relative to housing 302 to selectively adjust the frequency and amplitude of OPEC therapy administered by the OPEP 300 device. Similar to the adjustment mechanism 253 of the OPEP 200 device, a user can adjust the orientation of the camera input 304 in relation to the limiting element 330 in the OPEP 300 device by turning the adjustment dial 354, turning, thus, the bowl 372 and the wall 374 in relation to the limiting element 330 and the housing 302. A user can increase the frequency and amplitude of the OPEC therapy administered by the OPEC device 300 by turning the adjustment dial 354 and therefore wall 374 in a clockwise direction. Alternatively, a user can decrease the frequency and amplitude of OPEC therapy administered by the OPEC 300 device by turning the adjustment dial 354 and, therefore, the wall 374 in the counterclockwise direction. As shown in Figures 35 to 36, a protrusion 358 extending from housing 302 through a notch 376 on the adjustment dial 354 can be provided to limit the rotation of the adjustment dial 354, so that the allowable configurations of the OPEC device 300 are limited, and ideal operating conditions are maintained. [00080] Operating conditions similar to those described below with reference to the OPEC device 800 can also be realized for an OPEC device according to the OPEC device 300. FOURTH MODALITY [00081] Turning to Figures 39 to 40, a fourth embodiment of an OPEC 400 device is shown. Although the configuration of the OPEP 400 device is different from that of the OPEP 300 device and the OPEP200 device, the internal components and operation of the OPEP 400 device are the same in another way. For example, as seen in the front perspective view of Figure 39, a housing 402 of the OPEC device 400 includes a nozzle 409, a first chamber outlet 406 and a second chamber outlet 408 (best seen in Figures 41A to 41B) positioned opposite the first chamber outlet. The housing 402 is formed by a front section 401, a middle section 403 and a rear section 405, as well as an upper section 407 adapted to rotate in relation to the front section 401, the middle section 403 and the rear section 405. [00082] As seen in the cross-sectional view of Figure 40, the OPEC device 400 further includes a limiting element 430 operatively connected to a reed 432 by an axis (not shown), and a variable nozzle 436 that separates a first chamber 414 and a second chamber 418. The upper section 407 of housing 402 includes a frame 456 that has a seat 424 shaped to accommodate the limiting element 430, a lock 422 to prevent the limiting element 430 from opening in the wrong direction, as well as a upper support 426 and a lower support 428 around which the axis (not shown) that operationally connects the limiting element 430 and the vane 436 is rotatably mounted. In operation, the seat 422 defines the chamber inlet 404. Consequently, the limiting element 430 is rotatable in relation to the seat 422 and the chamber inlet 404. [00083] As in the previously described modalities, an exhalation flow path 410, identified by a dashed line, is formed between the nozzle 409 and at least one of the first chamber outlet 406 and the second chamber outlet 408. One more Instead, those skilled in the art will understand that the exhalation flow path 410 identified by the dashed line is exemplary, and that the air exhaled to the OPEC 400 device can flow in any number of directions or paths as it travels through nozzle 409 or chamber inlet 404 for first chamber outlet 406 or second chamber outlet 408. Due to the configuration of the OPEP 400 device, the exhalation flow path 410 differs from those of the modalities described above. More specifically, the exhalation flow path 410 starts at the nozzle 409 formed in the upper section 407 of the housing 402, passes through the chamber entrance 404, and enters a first chamber 114. In the first chamber 414, the exhalation flow path makes a 180 ° turn towards the front section 401 of housing 402, followed by a 90 ° turn towards the bottom of the OPEC device 400, in addition to a second chamber 418 of housing 402. The exhalation flow path 410 then makes a 90 ° turn towards the rear section 405 of housing 402, where it makes another 180 ° turn and passes through a variable nozzle 436, and enters the second chamber 418. In the second chamber 418, the exhalation flow 410 may exit the OPEC device 410 through at least one of the first chamber outlet 406 or the second chamber outlet 408. [00084] As seen in Figures 40 and 41A to B, the upper section 407 of the housing 402 is rotatable in relation to the front section 401, the middle section 403 and the rear section 405 of the housing 402. In this way, a user is able to rotate the upper section 407 with respect to the front section 401, the middle section 403 and the rear section 405 to selectively adjust the orientation of the chamber input 404 with respect to the limiting element 430 and the housing 402, and thereby selectively adjust the frequency and amplitude of OPEC therapy delivered by the OPEC device 400, similarly as previously described in relation to the adaptability of the OPEC device 200. For example, a user can increase the frequency and amplitude of OPEC therapy delivered by the OPEC device 400 by rotating the upper section 407 and, therefore, the seat 422, in relation to the front section 401, the middle section 403 and the rear section 405, towards the position shown in Figure 41A. Alternatively, a user can decrease the frequency and amplitude of OPEC therapy administered by the OPEC 400 device by rotating the upper section 407 and therefore the seat 422, in relation to the front section 401, the middle section 403 and the rear section 405, towards the position shown in Figure 41B. Additionally, as shown in Figures 40 and 41A to B, a protrusion 458 extending from the middle section 403 of the housing 402 can be provided to limit the rotation of the upper section 407 so that the allowable configurations of the OPEC device 400 are limited , and ideal operating conditions are maintained. [00085] Operating conditions similar to those described below with reference to the OPEC 800 device may also be achievable for an OPEC device according to the OPEC 400 device. [00086] Turning to Figures 42 to 47, several alternative modalities of the OPEC 100 device are shown. Although the modalities shown in Figures 42 to 47 and described below are alternative modalities of the OPEC 100 device, it should be understood that the disclosed modifications can be applied to any of the modalities described in this document. FIFTH MODE [00087] With reference to Figures 42 and 43, an OPEC 500 device is shown to have a chamber inlet bypass 578 adapted to allow air exhaled in a first chamber 514 without passing through chamber inlet 504. With the With the exception of chamber input bypass 578, the OPEP 500 device is otherwise configured and operates the same as the OPEP 100 device. As shown, the OPEP 500 device includes a housing 502 comprising a front section 501, a section intermediate 503 and a rear section 505. The housing is also associated with a nozzle 509 and includes a first chamber outlet 506 and a second chamber outlet (not shown) opposite the first chamber outlet 506. As seen in the cross-sectional view of Figure 43, the OPEC device 500 includes a limiting element 530 positioned in relation to a seat 524 around the chamber entrance 504 so that it can move between a closed position, where the flow of exhaled air through chamber inlet 504 is limited and an open position, in which the flow of exhaled air through chamber inlet 504 is less limited. The OPEP 500 device additionally includes a chamber inlet bypass 578 that allows a small amount of exhaled air to move past the chamber inlet 504 and the limiting element 530 at all times. An exemplary flow path 577 through chamber inlet bypass 578 is identified in Figure 43 by a dashed line. By allowing a small amount of exhaled air to bypass chamber inlet 504 and limiting member 530 through chamber inlet bypass 578, the range of OPEC therapy delivered by the OPEC device 500 is decreased, while the frequency remains substantially unchanged . [00088] Furthermore, a regulating member 579 extending from the nozzle 509 allows a user to selectively adjust the amount of exhaled air allowed to flow through the chamber inlet bypass 578. For example, as shown in Figure 43, a user it can rotate the nozzle 509 with respect to the front section 501 of the housing 502, thereby rotating the regulating member 579 with respect to the chamber inlet bypass 578, both to increase and to decrease the cross sectional area of the chamber inlet bypass 578 through which exhaled air can flow. In this way, the user can selectively adjust the OPEP 500 device to maintain optimal operating conditions. SIXTH MODE [00089] Referring to Figures 44 and 45, an OPEC device 600 is shown having a control port 680 adapted to allow the exhaled air to exit the respiratory treatment device 600 before entering a first chamber 614 of the OPEC device 600. With the exception of control port 680, the OPEP 600 device is otherwise configured and operates the same as the OPEP 100 device. As shown, the OPEP 600 device includes a housing 602 comprising a front section 601, an intermediate section 603 and a rear section 605. Housing 602 is also associated with a nozzle 609 and includes a first chamber outlet 606 and a second chamber outlet (not shown) positioned opposite the first chamber outlet 606. As seen in In cross-sectional view of Figure 45, the OPEC device 600 includes a limiting element 630 positioned in relation to a chamber inlet 604 so that it can move between a closed position, where and the flow of exhaled air through chamber inlet 604 is limited and an open position, in which the flow of exhaled air through chamber inlet 604 is less limited, as well as a variable nozzle 636 and a reed 632 operably connected to the element. limiter 630 by an axis (not shown). A control port 680 allows a small amount of exhaled air to exit the respiratory treatment device 600 before entering the first chamber 614 of the OPEC device 600. An exemplary flow path 681 through control port 680 is identified in Figure 45 dashed line. By allowing a small amount of exhaled air to exit the OPEC 600 device through control port 680, the amplitude and frequency of OPEC therapy delivered by the OPEC 600 device is decreased. [00090] In addition, the nozzle 609 can rotate with respect to the front section 601 of housing 602 to allow a user to selectively adjust the amount of exhaled air allowed to exit the respiratory treatment device 600 through control port 680. For example, as shown in Figure 45, a user can rotate nozzle 609 with respect to front section 601 to both increase and decrease the cross-sectional area of control port 680 through which exhaled air can flow. In this way, the user can selectively adjust the OPEP 600 device to maintain optimal operating conditions. [00091] Operating conditions similar to those described below in reference to the OPEC device 800 can also be achievable for an OPEC device according to the OPEC device 600. SEVENTH MODALITY [00092] Turning to Figures 46 and 47, an OPEC device 700 is shown having a first control port 780 adapted to allow the exhaled air to escape from the respiratory treatment device 700 before entering a first chamber 714 and a second control port 782 adapted to allow the exhaled air to escape from the respiratory treatment device 700 from the first chamber 714. With the exception of the first control port 780 and the second control port 782, the OPEC device 700 is another configured mode and operates the same as the OPEC device 100. As shown, the OPEC device 700 includes a housing 702 comprising a front section 701, an intermediate section 703 and a rear section 705. The housing is also associated with a nozzle 709 and includes a first chamber outlet 706 and a second chamber outlet (not shown) positioned opposite the first chamber outlet 706. As seen in the cross-sectional view of Figure 47, the OPEC device 700 includes a limiting element 730 positioned in relation to a chamber inlet 704 so that it can move between a closed position, in which the flow of exhaled air through the chamber inlet 704 is limited and an open position, in which the air flow exhaled through the chamber inlet 704 is less limited, as well as a variable nozzle 736 and a vane 732 operatively connected to the limiting element 730 by an axis (not shown). [00093] In addition, both the first control port 780 and the second control port 782 can be equipped with regulating members 779, 783 configured to allow a user to selectively adjust the amount of exhaled air allowed to leave the treatment device. breathing valve 700 through both the first control port 780 and the second control port 782. For example, as shown in Figures 46 and 47, regulating members 779, 783 are formed as a ring configured to rotate with respect to housing 702 both to increase as well as to decrease the cross-sectional area of the control door 780, 782 through which the exhaled air can flow. By selectively increasing the cross-sectional area of the first control door 780 through which exhaled air can flow, a user can decrease the amplitude and frequency of the OPEC therapy administered by the OPEC 700 device and vice versa. By selectively increasing the cross-sectional area of the second control port 782, a user can decrease the frequency of OPEC therapy administered by the OPEC 700 device and vice versa. In this way, a user can selectively adjust the OPEP 700 device to maintain optimal operating conditions. EIGHT MODE [00094] Turning to Figures 48 to 50, another embodiment of an OPEC 800 device is shown. The OPEP 800 device is similar to the OPEP 200 device in that it is selectively adjustable. As best seen in Figures 48, 50, 53 and 62, the OPEC device 800, as well as the OPEC device 200, includes an adjustment mechanism 853 adapted to change the relative position of a chamber inlet 804 in relation to a housing 802 and a limiting element 830, which in turn changes the rotation range of a reed 832 operatively connected thereto. As previously explained in relation to the OPEC 200 device, a user is therefore able to conveniently adjust both the frequency and the amplitude of the OPEC therapy delivered by the OPEC 800 device without opening the 802 housing and disassembling the OPEC device components. 800. The administration of OPEC therapy using the OPEC 800 device is otherwise the same as described above in relation to the OPEC 100 device. [00095] The OPEC device 800 comprises an 802 housing that has a front section 801, a rear section 805 and an inner housing 803. Like the OPEC devices described above, the front section 801, the rear section 805 and the housing internal 803 are separable so that the components contained therein can be periodically accessed, cleaned, or reconfigured, as required to maintain the ideal operating conditions. For example, as shown in Figures 48 to 50, the front section 801 and the rear section 805 of housing 802 are removably connected by means of a snap-fit coupling. [00096] The components of the OPEC device 800 are further illustrated in the exploded view of Figure 51. In general, in addition to the front section 801, the rear section 805 and the inner shell 803, the OPEC device 800 additionally comprises a nozzle 809, an inhalation port 811, a check valve 884 disposed between them, an adjustment mechanism 853, a limiting element 830, a reed 832 and a variable nozzle 836. [00097] As seen in Figures 52 and 53, the inner shell 803 is configured to fit within the housing 802 between the front section 801 and the back section 805 and particularly defines a first chamber 814 and a second chamber 818. The inner shell 803 is shown in more detail in the perspective and cross-sectional views shown in Figures 54 and 55. A first chamber outlet 806 and a second chamber outlet 808 are formed within the inner shell 803. An end 885 of the inner shell 803 is adapted to receive the variable nozzle 836 and maintain the variable nozzle 836 between the rear section 805 and the inner shell 803. An upper support 826 and a lower support 828 to support the adjustment mechanism 853 are formed, at least in part, within the inner shell 803. Just like flexible cylinder 271 and sealing edge 270 described above in relation to the OPEC device 200, inner shell 803 also includes a flexible cylinder 871 with a sealing edge 870 for engagement around a frame 856 of the adjustment mechanism 853. [00098] The vane 832 is shown in more detail in the perspective view shown in Figure 56. An axis 834 extends from the vane 832 and is keyed to engage a corresponding keyed part within a hole 865 of the limiting element 830 Thus, the axis 834 operatively connects the vane 832 with the limiting element 830 so that the vane 832 and the limiting element 830 rotate in unison. [00099] The limiting element 830 is shown in more detail in the perspective views shown in Figures 57 and 58. The limiting element 830 includes a keyed hole 865 to receive the axis 834 extending from the reed 832 and additionally includes a lock 822 that limits the permissive rotation of the limiting element 830 with respect to a seat 824 of the adjusting member 853. As shown in the front view of Figure 59, as well as the limiting element 130, the limiting element 830 further comprises an offset designed to facilitate movement of the element limiter 830 between a closed position and an open position. More specifically, a larger surface area of the face 840 of the limiting element 830 is positioned on one side of the hole 865 to receive the axis 834 than on the other side of the hole 865. As described above in relation to the limiting element 130, this deviation produces a torque opening around axis 834 during exhalation periods. [000100] The adjustment mechanism 853 is shown in more detail in the front and rear perspective views of Figures 60 and 61. In general, the adjustment mechanism includes a frame 856 adapted to engage the sealing edge 870 of the flexible cylinder 871 formed in the inner casing 803. A circular opening in frame 856 forms a seat 824 formed to accommodate stop member 830. In this embodiment, seat 824 also defines chamber inlet 804. Adjustment mechanism 853 additionally includes an arm 854 configured to extend from frame 856 to a position beyond housing 802 in order to allow a user to selectively adjust the orientation of adjustment mechanism 853, and therefore, chamber input 804, when the OPEC device 800 is fully assembled. Adjustment mechanism 853 also includes an upper support 885 and a lower support 886 for receiving the axis 834. [000101] A vane assembly 832, the adjusting mechanism 853 and the limiting element 830 is shown in the perspective view of Figure 62. As explained earlier, the vane 832 and the limiting element 830 are operatively connected by the axis 834 so that the rotation of the reed 832 results in the rotation of the limiting element 830 and vice versa. In contrast, the adjustment mechanism 853, and therefore the seat 824 that define the chamber entrance 804, is configured to rotate with respect to the reed 832 and the limiting element 830 around the axis 834. In this way, a user can rotate arm 854 to selectively adjust the orientation of chamber input 804 with respect to limiter element 830 and housing 802. For example, a user can increase the frequency and amplitude of OPEC therapy delivered by the OPEC device 800 by rotating arm 854 , and therefore frame 856, in a clockwise direction. Alternatively, a user can decrease the frequency and amplitude of the OPEC therapy delivered by the OPEC 800 device by turning the adjustment arm 854, and therefore the frame 256, counterclockwise. In addition, as shown, for example, in Figures 48 and 50, clues can be provided in the 802 housing to assist the user in establishing the appropriate configuration of the OPEP 800 device. [000102] The variable nozzle 836 is shown in more detail in the front and rear perspective views of Figures63 and 64. The variable nozzle 836 in the OPEC device 800 is similar to the variable nozzle 236 described above in relation to the OPEC device 200, except for the fact that the variable nozzle 836 also includes a base plate 887 configured to fit within an end 885 (see Figures 54 and 55) of the inner shell 803 and to hold the variable nozzle 836 between the rear section 805 and the inner shell 803. Like the variable nozzle 236, the variable nozzle 836 and the base plate 887 can be made of silicone. [000103] The check valve 884 is shown in more detail in the front perspective view of Figure 65. In general, the check valve 884 comprises a post 888 adapted for mounting in the front section 801 of the housing802 and a flap 889 adapted for folding or rotate with respect to post 888 in response to a force or pressure on tab 889. Those skilled in the art will find that other one-way valves can be used in this and other modalities described in this document without departing from the teachings of the present description. As seen in Figures 52 and 53, check valve 884 can be positioned in housing 802 between nozzle 809 and inhalation port 811. [000104] As discussed above in relation to the OPEC 100 device, the OPEC 800 device can be adapted for use with other interfaces or additional interfaces, such as an aerosol dispensing device. In this regard, the OPEC 800 device is equipped with an inhalation port 811 (best seen in Figures 48, 49, 51 and 53) in fluid communication with the nozzle 809. As noted above, the inhalation port may include a separate check valve 884 (best seen in Figures 52, 53 and 65) configured to allow a user of the OPEC 800 device to either inhale the surrounding air through check valve 884 or exhale through chamber inlet 804, without removing the nozzle 809 of the OPEC device 800 between periods of inhalation and exhalation. In addition, the commercially available aerosol dispensing devices mentioned above can be connected to inhalation port 811 for simultaneous administration of aerosol therapy (by inhalation) and OPEC therapy (by exhalation). [000105] The OPEC 800 device and the components described above are further illustrated in the cross-sectional views shown in Figures 52 and 53. For purposes of illustration, the cross-sectional view of Figure 52 is shown without all the internal components of the device of OPEC 800. [000106] Front section 801, rear section 805 and inner casing 803 are assembled to form a first chamber 814 and a second chamber 818. Like the OPEC device 100, an exhalation flow path 810, identified by a dashed line, is defined between the nozzle 809 and at least one of the first chamber outlet 806 (best seen in Figures 52,53 and 55) and the second chamber outlet 808 (best seen in Figure 54), both of which are formed inside the inner shell 803. As a result of the inhalation port 811 and the check valve 848, the exhalation flow path 810 starts at the nozzle 809 and is directed to the chamber inlet 804, which in operation may or may not be blocked by the element limiter 830. After passing through chamber inlet 804, exhalation flow path 810 enters the first chamber 814 and makes a 180 ° turn towards variable nozzle 836. After passing through hole 838 of the variable nozzle 836, the flow path exhalation 810 enters the second chamber 818. In the second chamber 818, the exhalation flow path 810 can leave the second chamber 818 and finally the housing 802, through at least one of the first chamber outlet 806 or the second chamber outlet 808. Those skilled in the art will find that the exhalation flow path 810 identified by the dashed line is exemplary and that the air exhaled in the OPEC 800 device can flow in any number of directions or paths as it passes through nozzle 809 or chamber inlet 804 to first chamber outlet 806 or second chamber outlet 808. As noted earlier, the administration of OPEC therapy using the OPEC device 800 is otherwise the same as described above in relation to the OPEC device 100. [000107] For example only, the following operating conditions, or performance characteristics, can be achieved by an OPEC device according to the OPEC device 800, with the setting dial 854 set for increased frequency and amplitude: [000108] The observed frequency and amplitude can decrease, for example, by approximately 20% with the setting dial 854 established for decreased frequency and amplitude. Other frequency and amplitude targets can be achieved by varying the particular configuration or dimensioning of elements, for example, increasing the length of the 832 reed results in a lower frequency, while decreasing the size of the 838 orifice results in a higher frequency. The above example is merely a possible set of operating conditions for an OPEC device according to the modality described above. NINTH MODE [000109] Turning to Figures 66 to 69, another embodiment of a respiratory treatment device 900 is shown. Unlike the OPEC devices previously described, the respiratory treatment device 900 is configured to deliver oscillating pressure therapy through both exhalation and inhalation. Those skilled in the art will find that the concepts described below in relation to the respiratory treatment device 900 can be applied to any of the OPEC devices described above, so that oscillating pressure therapy can be administered through both exhalation and inhalation. Similarly, the respiratory treatment device 900 can incorporate any of the above concepts associated with the OPEC devices described above, including, for example, a variable mouthpiece, an inhalation port adapted for use with an aerosol dispensing device for administration of aerosol therapy, an adjustment mechanism, a chamber input bypass, one or more control ports, etc. [000110] As shown in Figures 66 and 67, the respiratory treatment device 900 includes a housing 902 that has a front section 901, an intermediate section 903 and a rear section 905. Like the OPEC devices described above, the housing 902 it is openable so that the contents of the housing 902 can be accessed for cleaning and / or selective replacement of the components contained therein to maintain ideal operating conditions. Housing 902 additionally includes a first opening 912, a second opening 913 and a third opening 915. [000111] Although the first opening 912 is shown in Figures 66 and 67 in association with a nozzle 909, the first opening 912 can alternatively be associated with other user interfaces, for example, a gas mask or a breathing tube. The second opening 913 includes a one-way exhalation valve 990 configured to allow air exhaled to housing 902 to escape from housing 902 by exhaling into the first opening 912. The third opening 915 includes a one-way inhalation valve 984 configured to allow air outside the housing 902 enter the housing 902 by inhalation at the first opening 912. As shown in greater detail in Figure 67, the respiratory treatment device 900 additionally includes a collecting plate 993 that has an exhalation passage 994 and a passage inhalation 995. A check valve 991 is adapted for mounting inside the collecting plate 993 adjacent to the exhalation passage 994 so that the check valve 991 opens in response to the exhaled air at the first opening 912 and closes in response to the air inhaled through the first opening 912. A separate check valve 992 is adapted for mounting inside the collecting plate 993 adjacent to the country inhalation message 995 so that the check valve 992 closes in response to the exhaled air at the first opening 912 and opens in response to the inhaled air through the first opening 912. The respiratory treatment device 900 also includes a limiting element 930 and a reed 932 operatively connected by an axis 934, the assembly of which can operate in the same manner as described above in relation to the OPEC devices described. [000112] Now referring to Figures 68 and 69, perspective views in cross section are shown taken along lines I and II, respectively, in Figure 66. The respiratory treatment device 900 delivers oscillating pressure therapy through both inhalation and exhalation in a manner similar to that shown and described above in relation to OPEC devices. As described in more detail below, the OPEC 900 device includes a plurality of chambers (i.e., more than one). The air transmitted through the first opening 912 of housing 902, whether inhaled or exhaled, passes through a flow path that passes, at least in part, through a limiting element 930 housed in a first chamber 914 and through a second chamber 918 that houses a reed 932 operatively connected to the limiting element 930. In this regard, at least a part of the flow path for both exhaled and inhaled air from the first opening 92 is superimposed and occurs in the same direction. [000113] For example, an exemplary flow path 981 is identified in Figures 68 and 69 by a dashed line. Similar to the OPEC devices previously described, the limiting element 930 is positioned in the first chamber 914 and can move relative to a chamber inlet 904 between a closed position, in which the air flow through the chamber inlet 904 is limited and an open position, where the flow of air through chamber 904 is less limited. After passing through chamber inlet 904 and entering first chamber 914, the exemplary flow path 981 turns 180 °, or reverses longitudinal directions (that is, flow path 981 is bent over itself), then after the exemplary flow path 981 passes through an orifice 938 and enters the second chamber 918. Like the OPEC devices described above, the reed 932 is positioned in the second chamber 918 and is configured to switch between a first position and a second position in response to increased pressure adjacent the reed, which in turn causes the operatively connected limiting element 930 to move repeatedly between the closed position and the open position. Depending on the position of the reed 932, the air flowing along the exemplary flow path 981 is directed to either a first chamber outlet 906 or a second chamber outlet 908. Consequently, as the inhaled or exhaled air passes through the exemplary flow path 98, the pressure at chamber inlet 904 oscillates. [000114] The oscillating pressure at the chamber inlet 904 is effectively transmitted back to a user of the respiratory treatment device 900, that is, at the first opening 912, through a series of chambers. As seen in Figures 68 and 69, the respiratory treatment device includes an additional first chamber 996, an additional second chamber 997 and an additional third chamber 998, which are described in more detail below. [000115] The nozzle 909 and the first additional chamber 996 are in communication through the first opening 912 in housing 902. The first additional chamber 996 and the second additional chamber 997 are separated by the collecting plate 993 and are in communication through the passage exhalation valve 994. The non-return valve 991 mounted adjacent to exhalation passage 994 is configured to open in response to the exhaled air in the first opening 912 and to close in response to the inhaled air through the first opening 912. [000116] The first additional chamber 996 and the third additional chamber 998 are also separated by the collecting plate 993 and are in communication via the inhalation passage 995. The non-return valve 992 mounted adjacent to the inhalation passage 995 is configured to close in response to exhaled air at first opening 912 and opening in response to inhaled air through first opening 912. [000117] The air around the respiratory treatment device 900 and the second additional chamber 997 are in communication via the third opening 915 in housing 902. Check valve 984 is configured to close in response to the air exhaled at the first opening 912 and open in response to inhaled air through the first opening 912. [000118] The air around the respiratory treatment device 900 and the additional third chamber 998 are in communication via the second opening 913 in housing 902. The non-return valve 990 mounted adjacent to the second opening 913 is configured to open in response to the exhaled air at the first opening 912 and to close in response to the inhaled air through the first opening 912. The additional third chamber 998 is also in communication with the second chamber 918 through the first chamber outlet 906 and the second chamber outlet 908 . [000119] Now referring to Figures 70 and 71, the cross-sectional perspective views taken along lines I and II, respectively, of Figure 66, illustrate an exhalation flow path 910 exemplified between the first opening 912, or the nozzle 909 and the second opening 9 3. In general, upon exhalation by a user in the first opening 912 of the housing 902, pressure is formed in the first additional chamber 996, causing the check valve 991 to open and the valve retainer 992 is closed. Exhaled air then enters the second additional chamber 997 through the exhalation passage 994 and pressure forms in the second additional chamber 997, causing the check valve 984 to close and the limiting element 930 to open. The exhaled air then enters the first chamber 914 through the chamber inlet 904, reverses longitudinal directions and accelerates through the orifice 938 that separates the first chamber 914 and the second chamber 918. Depending on the orientation of the vane 932, the exhaled air then exits the second chamber 918 through one of both the first chamber outlet 906 and the second chamber outlet 908, just after it enters the third additional chamber 998. As pressure builds up in the third additional chamber 998, the check valve 990 opens, allowing exhaled air to exit housing 902 through second opening 913. Once the exhaled air flow along exhalation flow path 910 is established, vane 932 alternates between a first position and a second position, which in turn causes the limiting element 930 to move between the closed position and the open position, as described above in relation to OPEC devices. In this way, the respiratory treatment device 900 provides oscillating therapy by exhalation. [000120] Now referring to Figures 72 and 73, different cross-sectional perspective views taken along lines I and II, respectively, of Figure 66, illustrate an exemplary inhalation flow path 999 formed between the third opening 915 and the first opening 912, or the nozzle 909. In general, upon inhalation by a user through the first opening 912, pressure drops in the first additional chamber 996, causing the check valve 991 to close and the check valve 992 to open. . As air is inhaled from the third additional chamber 998 into the first additional chamber 996 through the inhalation passage 995, the pressure in the third additional chamber 998 begins to drop, causing the check valve 990 to close. As the pressure continues to drop in the additional third chamber 998, air is sucked from the second chamber 918 through the first chamber outlet 906 and the second chamber outlet 908, As air is sucked from the second chamber 9 8, air is also sucked from the first chamber 914 through the orifice 938 that connects the second chamber 918 and the first chamber 914. As air is sucked from the first chamber 914, air is also sucked from the additional second chamber 997 through the inlet chamber 904, causing the pressure in the second additional chamber 997 to drop and the check valve 984 to open, thus allowing air to enter the housing 902 through the third opening 915. Due to the differential pressure between the first additional chamber 996 and the second additional chamber 997, the check valve 991 remains closed. Once the flow of inhaled air along the inhalation flow path 999 is established, the reed 932 alternates between a first position and a second position, which in turn causes the limiting element 930 to move between the closed position and open position, as described above in relation to OPEC devices. In this way, the respiratory treatment device 900 provides oscillating therapy by inhalation. [000121] Now referring to Figure 74, a front perspective view is shown of the OPEC 800 device connected with an aerosol dispensing device in the form of a nebulizer 899 via the inhalation port 811. The system comprising the delivery device OPEP 800 connected to the 899 nebulizer is configured to provide both oscillating pressure therapy and aerosol therapy, as described above. The combination of the OPEP 800 device and the 899 nebulizer, however, is exemplary. Alternative combinations of the OPEC devices described in this document and the aerosol dispensing devices, such as those identified above, are also envisaged. [000122] Those skilled in the art will find that the various concepts described above in relation to a particular modality of an OPEC device can also be applied to any of the other modalities described in this document, even if not specifically shown or described in relation to other modalities. For example, any of the modalities described in this document may include a variable mouthpiece, an inhalation port adapted for use with an aerosol dispensing device for administering aerosol therapy, an adjustment mechanism to adjust the relative position of the inlet. chamber and / or permissible range of motion by a limiting element, a chamber input bypass, one or more control ports, etc. [000123] Although the foregoing description is provided in the context of an OPEC device, it will also be apparent to those skilled in the art that any breathing device may benefit from the various teachings contained in this document. The preceding description has been presented for purposes of illustration and description and is not intended to be exhaustive or to limit inventions to the precise forms disclosed. It will be apparent to those skilled in the art that the present inventions are susceptible to many variations and modifications within the scope of the following claims. EXAMPLE DEPLOYMENTS [000124] In a deployment, a respiratory treatment device includes a housing including at least one chamber, a chamber inlet configured to receive exhaled air in at least one chamber, and at least one chamber outlet configured to allow the exhaled air to escape at least one camera. An exhalation flow path is defined between the chamber inlet and at least one chamber outlet and a limiting element is positioned in the exhalation flow path, the limiting element being able to move between a closed position, in which one Exhaled air flow through the chamber inlet is limited and an open position, in which the exhaled air flow through the chamber inlet is less limited. An orifice is positioned along the exhalation flow path through which the exhaled air passes and a vane is positioned adjacent to the orifice, the vane being operatively connected to the limiting element and configured to switch between a first position and a second position in response to increased pressure adjacent to the reed. In addition, the limiting element moves between the closed position and the open position in response to the reed alternating between the first position and the second position. [000125] The limiting element can be positioned in a first chamber and the reed can be positioned in a second chamber. The first chamber and the second chamber can be connected to the hole. An orifice size can be configured to change in response to the flow of air exhaled through the orifice. The limiting element can be a butterfly valve. The vane can be operatively connected to the limiting element by an axis. One face of the limiting element can rotate about an axis of rotation and the face of the limiting element can be radially displaced from the axis of rotation. The face of the limiting element may also have a larger surface area positioned on one side of the axis than on the other side of the axis. A chamber input orientation can be selectively adjustable. A chamber inlet bypass can be configured to allow air exhaled in at least one chamber without passing through the chamber inlet. A control port can be configured to allow exhaled air to exit the respiratory treatment device before entering at least one chamber. A control port can also be configured to allow exhaled air to escape from the first chamber. An inhalation port can be in fluid communication with a user interface and a check valve can be configured to allow air to flow through the inhalation port to the user interface upon inhalation. The inhalation port can also be configured to receive an aerosol medication from an aerosol dispensing device. The exhalation flow path can be doubled over itself. [000126] In another implantation, an OPEC therapy performance method includes receiving an exhaled airflow along a defined exhalation flow path between an inlet and an outlet of a respiratory treatment device, directing the airflow exhaled to a reed, alternate the reed between a first position and a second position in response to the exhaled air flow, and move a limiting element in response to the reciprocal movement of the reed between a closed position, in which an exhaled air flow through from the chamber inlet is limited and an open position, in which the flow of air exhaled through the chamber inlet is less limited. [000127] In another implantation, an OPEC therapy performance method includes receiving an exhaled air flow along a defined exhalation flow path between an inlet and an outlet of a respiratory treatment device, accelerating the air flow exhaled through an orifice positioned along the exhalation flow path, alternate a vane adjacent to the orifice between a first position and a second position in response to the exhaled air flow through the orifice, and move a limiting element in response to movement reciprocal of the reed between a closed position, in which the exhaled air flow along the exhalation flow path is limited and an open position, in which the exhaled air flow along the exhalation flow path is less limited. The method may also include changing an orifice size in response to the flow of air exhaled through the orifice.
权利要求:
Claims (32) [0001] 1 - Respiratory treatment device comprising: a housing (102, 202, 302, 402, 502, 602, 702, 802) that includes at least one chamber; a chamber inlet (104, 204, 304, 404, 504, 604, 704, 804) configured to receive exhaled air into at least one chamber; at least one chamber outlet (106, 108, 206, 208, 306, 406, 408, 506, 606, 706, 806, 808 ) configured to allow exhaled air to escape from at least one chamber; an exhalation flow path (110, 210, 310, 410, 810) defined between the chamber inlet and at least one chamber outlet; a limiting element ( 130, 230, 330, 430, 530, 630, 730, 830) positioned in the exhalation flow path, the limiting element being movable between a closed position, where an exhaled air flow along the exhalation flow path is limited , and an open position, where the flow of exhaled air along the exhalation flow path is less limited; and, a reed (132, 232, 332, 432, 632, 732, 832) in fluid communication with the exhalation flow path, the reed operatively connected to the limiting element and configured to switch between a first position and a second position, in response to an exhaled air flow along the exhalation flow path, characterized by the fact that the limiter and the vane are axially misaligned along a common axis of rotation. [0002] 2 - Respiratory treatment device, according to claim 1, characterized by the fact that in the first position the reed is positioned to direct the flow of exhaled air to leave at least one chamber through a first chamber exit from at least one chamber outlet, and in the second position the reed is positioned to direct the exhaled air flow to exit at least one chamber through a second chamber outlet of at least one chamber outlet. [0003] 3 - Respiratory treatment device, according to claim 1, characterized by the fact that the limiting element is positioned in a first chamber and the reed is positioned in a second chamber. [0004] 4 - Respiratory treatment device, according to claim 3, characterized by the fact that the first chamber and the second chamber are connected by an orifice (138). [0005] 5 - Respiratory treatment device according to claim 4, characterized by the fact that an orifice size is configured to change in response to the flow of exhaled air through the orifice. [0006] 6 - Respiratory treatment device, according to claim 1, characterized by the fact that the limiting element is a butterfly valve. [0007] 7 - Respiratory treatment device, according to claim 1, characterized by the fact that the reed is operatively connected to the limiting element by an axis (134, 255, 834). [0008] 8 - Respiratory treatment device, according to claim 7, characterized by the fact that a face of the limiting element is rotatable about an axis of rotation. [0009] 9 - Respiratory treatment device, according to claim 8, characterized by the fact that the face of the limiting element is radially out of alignment with the axis of rotation. [0010] 10 - Respiratory treatment device, according to claim 8, characterized by the fact that the face of the limiting element has a larger surface area positioned on one side of the axis than on the other side of the axis. [0011] 11 - Respiratory treatment device, according to claim 1, characterized by the fact that an orientation of the chamber entrance is selectively adjustable. [0012] Breathing treatment device according to claim 1, characterized by the fact that it additionally comprises a bypass chamber inlet (578) configured to allow exhaled air into at least one chamber without passing through the chamber inlet. [0013] 13 - Respiratory treatment device according to claim 1, characterized in that it additionally comprises a control port (680, 780) configured to allow the exhaled air to exit the respiratory treatment device before entering at least one chamber . [0014] 14 - Respiratory treatment device according to claim 3, characterized by the fact that it additionally comprises a control port configured to allow the exhaled air to escape from the first chamber. [0015] 15. Respiratory treatment device according to claim 1, characterized by the fact that it additionally comprises an inhalation port (211, 811) in fluid communication with a user interface. [0016] 16. Respiratory treatment device according to claim 15, characterized in that it additionally comprises a one-way valve (884) configured to allow air to flow through the inhalation port to the user interface during inhalation. [0017] 17. Respiratory treatment device according to claim 15, characterized by the fact that the inhalation port is adapted to receive an aerosol medication from an aerosol delivery device. [0018] 18 - Respiratory treatment device, according to claim 1, characterized by the fact that the exhalation flow path is articulated on itself. [0019] 19. Respiratory treatment device according to claim 17, characterized by the fact that the aerosol delivery device is connected to the inhalation port. [0020] 20 - Respiratory treatment device, which comprises: housing that includes at least one chamber; the chamber inlet configured to receive exhaled air into at least one chamber; at least one chamber outlet configured to allow the exhaled air to escape from the hair at least one chamber; an exhalation flow path defined between the chamber inlet and at least one chamber outlet; a limiting element positioned in the exhalation flow path, the limiting element being mobile in response to an exhaled air flow along the exhalation flow path between a closed position, where an exhaled air flow along the exhalation flow path is limited, and an open position, where the exhaled air flow along the exhalation flow path is less limited; and, a variable nozzle positioned in the exhalation flow path so that the exhalation flow path passes through a variable nozzle orifice, characterized by the fact that the size of the orifice is configured to increase in response to the exhaled air flow through orifice. [0021] 21 - Respiratory treatment device according to claim 20, characterized by the fact that it additionally comprises a reed positioned adjacent to the orifice, the reed being operatively connected to the limiting element and configured to move the limiting element between the closed position and the open position in response to an increase in pressure adjacent to the reed. [0022] 22 - Respiratory treatment device, according to claim 20, characterized by the fact that the variable nozzle is positioned downstream of the limiting element in the exhalation flow path. [0023] 23 - Respiratory treatment device, according to claim 20, characterized by the fact that the orifice of the variable nozzle is rectangular. [0024] 24 - Respiratory treatment device according to claim 21, characterized by the fact that the orifice of the variable nozzle remains rectangular after an increase in the size of the orifice in response to the flow of exhaled air through the orifice. [0025] 25 - Respiratory treatment device according to claim 20, characterized in that the orientation of the chamber entrance is selectively adjustable. [0026] 26 - Respiratory treatment device according to claim 20, characterized by the fact that it additionally comprises a chamber inlet with bypass configured to allow the exhaled air into at least one chamber, without passing through the chamber inlet. [0027] Respiratory treatment device according to claim 20, characterized in that it additionally comprises a control port configured to allow the exhaled air to exit the respiratory treatment device before entering at least one chamber. [0028] 28 - Respiratory treatment device according to claim 20, characterized in that it additionally comprises an inhalation port in fluid communication with a user interface. [0029] Respiratory treatment device according to claim 28, characterized in that it additionally comprises a one-way valve configured to allow air to flow through the inhalation port to the user interface during inhalation. [0030] Respiratory treatment device according to claim 28, characterized by the fact that the inhalation port is adapted to receive an aerosol medication from an aerosol delivery device. [0031] 31 - Respiratory treatment device, according to claim 20, characterized by the fact that the exhalation flow path is articulated on itself. [0032] 32 - Respiratory treatment device according to claim 30, characterized by the fact that the aerosol delivery device is connected to the inhalation port.
类似技术:
公开号 | 公开日 | 专利标题 BR112013031207B1|2020-12-08|respiratory treatment device JP6246884B2|2017-12-13|Vibratory positive air pressure device JP2021100594A|2021-07-08|Respiratory treatment device AU2013205095B2|2016-03-17|Oscillating positive expiratory pressure device US10953278B2|2021-03-23|Oscillating positive expiratory pressure device BR112015012466B1|2021-11-16|RESPIRATORY TREATMENT DEVICE CA3149500A1|2012-12-13|Oscillating positive expiratory pressure device
同族专利:
公开号 | 公开日 CN107029333A|2017-08-11| CA3010658A1|2012-12-13| JP6038903B2|2016-12-07| EP3415189A1|2018-12-19| RU2615280C2|2017-04-04| US20210330926A1|2021-10-28| PL2717953T3|2019-01-31| CA3096365A1|2012-12-13| AU2018217337A1|2018-09-06| JP2021020095A|2021-02-18| US10413698B2|2019-09-17| US20160310695A1|2016-10-27| IN2014CN00024A|2015-08-21| RU2013155009A|2015-07-20| EP2717953B1|2018-08-08| ES2687150T3|2018-10-23| JP6784797B2|2020-11-11| US9358417B2|2016-06-07| CA2837057C|2018-08-28| MX340914B|2016-07-29| CA3010658C|2020-12-01| US11040167B2|2021-06-22| JP6527123B2|2019-06-05| PT2717953T|2018-11-16| AU2012265933B2|2016-03-17| JP2017047249A|2017-03-09| JP2014518744A|2014-08-07| EP2717953A2|2014-04-16| US20120304988A1|2012-12-06| DK2717953T3|2018-11-12| JP2019146996A|2019-09-05| WO2012168780A2|2012-12-13| EP2717953A4|2014-12-10| AU2012265933A1|2013-05-09| US20190167940A1|2019-06-06| AU2016203797A1|2016-06-30| USD731050S1|2015-06-02| MX2013014309A|2014-01-31| BR112013031207A2|2017-01-24| CA2837057A1|2012-12-13| USD776804S1|2017-01-17| US9981106B2|2018-05-29| CN107029333B|2020-02-21| TR201815841T4|2018-11-21| CN103917266A|2014-07-09| US20180214662A1|2018-08-02| WO2012168780A3|2013-03-14|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题 US393869A|1888-12-04|Inhaler | US938808A|1909-05-03|1909-11-02|Silas T Yount|Therapeutic device.| US2670739A|1951-07-02|1954-03-02|Charles M Mcneill|Inhaler| US2918917A|1955-03-02|1959-12-29|John H Emerson|Apparatus for vibrating portions of a patient's airway| US3710780A|1971-08-05|1973-01-16|R Milch|Respiratory device with variable expiratory pressure resistance| US3834383A|1972-12-11|1974-09-10|Puritan Bennett Corp|Respiration apparatus with flow responsive control valve| US3908987A|1973-09-27|1975-09-30|John R Boehringer|Controlled positive end pressure expiratory device| US4054134A|1975-09-15|1977-10-18|Kritzer Richard W|Respirators| US4182366A|1976-01-08|1980-01-08|Boehringer John R|Positive end expiratory pressure device| US4062358A|1976-04-21|1977-12-13|Kritzer Richard W|Respirators| US4231375A|1977-10-20|1980-11-04|Boehringer John R|Pulmonary exerciser| FI56120C|1978-04-18|1979-12-10|Taisto Haekkinen|VALVE AVSEDD FOER RESPIRATOR ELLER FOER ANNAN UPPLIVNINGSANVAENDNING LAEMPAD ANORDNING| US4198969A|1978-10-06|1980-04-22|Baxter Travenol Laboratories, Inc.|Suction-operated nebulizer| US4226233A|1978-10-10|1980-10-07|Longevity Products, Inc.|Respirators| USD266701S|1978-11-06|1982-10-26|Bosch-Siemens Hausgerate Gmbh|Ultrasonic nebulizer| US4221381A|1978-12-26|1980-09-09|Albany International Corp.|Respiratory exerciser| US4436090A|1979-01-22|1984-03-13|Darling Phillip H|Piston actuated, pilot valve operated breathing regulator| US4275722A|1979-05-04|1981-06-30|Sorensen Harry D|Respiratory exerciser and rebreathing device| US4327740A|1979-11-19|1982-05-04|Clyde Shuman|Incentive spirometer| US4298023A|1980-09-09|1981-11-03|Mcginnis Gerald E|Spring loaded exhalation valve| US5862802A|1981-04-03|1999-01-26|Forrest M. Bird|Ventilator having an oscillatory inspiratory phase and method| USD272094S|1981-05-26|1984-01-03|Advanced Technology Products, Inc.|Pressurized medicament dispenser and monitor| US4403616A|1981-06-09|1983-09-13|K-Med, Inc.|Expiratory breathing exercise device| US4470412A|1982-03-19|1984-09-11|Trutek Research, Inc.|Inhalation valve| US4566452A|1982-07-12|1986-01-28|American Hospital Supply Corporation|Nebulizer| JPH049060B2|1983-11-04|1992-02-19| US4601465A|1984-03-22|1986-07-22|Roy Jean Yves|Device for stimulating the human respiratory system| US4611591A|1984-07-10|1986-09-16|Sharp Kabushiki Kaisha|Expiration valve control for automatic respirator| US4651731A|1984-09-17|1987-03-24|Figgie International Inc.|Self-contained portable single patient ventilator/resuscitator| US4739987A|1985-10-28|1988-04-26|Nicholson Marguerite K|Respiratory exerciser| US4770413A|1987-04-27|1988-09-13|Mba Healthcare Products, Inc.|Breathing exercise device| US4981295A|1987-05-11|1991-01-01|City Of Hope|Respiratory training using feedback| US5018517A|1987-10-22|1991-05-28|Claude Liardet|Expiration-resisting apparatus designed for improving pulmonary ventilation| US4951661A|1988-06-08|1990-08-28|Thayer Medical Corporation|Quick-connect adapter valve for connecting nebulizer and fluid ventilator hose| DE3822949C2|1988-07-07|1991-08-01|Draegerwerk Ag, 2400 Luebeck, De| EP0372148A1|1988-12-09|1990-06-13|Erik Folke Norell|Lung exercising device| US5012804A|1989-03-06|1991-05-07|Trudell Medical|Medication inhaler with adult mask| US5012803A|1989-03-06|1991-05-07|Trudell Medical|Modular medication inhaler| BE1004384A3|1989-08-03|1992-11-10|Labaere Emmanuel|Device for applying on and techniques exhalation.| GB9001505D0|1990-01-23|1990-03-21|Ferraris Dev & Eng Co Ltd|Ventilatory instrument for measuring peak expiratory flow| SG45171A1|1990-03-21|1998-01-16|Boehringer Ingelheim Int|Atomising devices and methods| US5042467A|1990-03-28|1991-08-27|Trudell Medical|Medication inhaler with fitting having a sonic signalling device| NZ233745A|1990-05-21|1993-02-25|Asthma Int Res|Single forced expiration airflow meter with rotating vane: maximum airflow indication retained until meter reset| DE4022393C2|1990-07-13|1993-06-24|Marquardt, Klaus, 7522 Philippsburg, De| AU6130594A|1991-03-05|1994-08-15|Miris Medical Corporation|Method and device for correcting the drift offset of a pressure sensor of a flowmeter| US6119688A|1991-08-26|2000-09-19|3M Innovative Properties Company|Powder dispenser| USD337636S|1991-09-12|1993-07-20|Devilbiss Health Care, Inc.|Ultrasonic medicament nebulizer| EP0540774B1|1991-11-07|1995-05-03|PAUL RITZAU PARI-WERK GmbH|Fluid atomizing device| US5277195A|1992-02-03|1994-01-11|Dura Pharmaceuticals, Inc.|Portable spirometer| US5345930A|1992-02-10|1994-09-13|National Research Council Canada Intellectual Property Services Office|Method and apparatus for assisting expulsional movement of pulmonary secretions via supramaximal flows| CH685475A5|1992-04-10|1995-07-31|Varioraw Percutive Sa|specific therapeutic device in the respiratory field.| US5647345A|1992-05-12|1997-07-15|Saul; Gilbert D.|Respiratory stimulator & methods of use| NZ250105A|1992-11-09|1996-07-26|Monaghan Canadian Ltd|Inhalator mask; one-way valve opens upon exhalation| US7004162B1|1992-11-09|2006-02-28|Canadian Monaghan, Ltd.|Exhalation valve| US5372128A|1993-04-14|1994-12-13|Habley Medical Technology Corporation|Fluidizing powder inhaler| DK0714314T3|1993-08-18|1999-06-23|Fisons Plc|Respirator with respiratory control| US5655520A|1993-08-23|1997-08-12|Howe; Harvey James|Flexible valve for administering constant flow rates of medicine from a nebulizer| US5570682A|1993-12-14|1996-11-05|Ethex International, Inc.|Passive inspiratory nebulizer system| US5479920A|1994-03-01|1996-01-02|Vortran Medical Technology, Inc.|Breath actuated medicinal aerosol delivery apparatus| US5598839A|1994-04-20|1997-02-04|Diemolding Corporation|Positive expiratory pressure device| DE4416575A1|1994-05-11|1995-11-16|Ulrich H Prof Dr Med Cegla|Therapy device| US5848588A|1994-05-25|1998-12-15|Trudell Medical Group|Backpiece for receiving an MDI adapter in an aerosolization spacer| GB9410935D0|1994-06-01|1994-07-20|Dranez Anstalt|Ventilator apparatus| US5816246A|1994-09-15|1998-10-06|Mirza; M. Zubair|Electronic pocket spirometer| US5613489A|1994-12-07|1997-03-25|Westmed, Inc.|Patient respiratory system drug applicator| US5540220A|1994-12-08|1996-07-30|Bear Medical Systems, Inc.|Pressure-limited, time-cycled pulmonary ventilation with volume-cycle override| US5613497A|1995-01-03|1997-03-25|The D & T, Inc.|Miniature peak flow meter| US6083141A|1995-02-10|2000-07-04|Hougen; Everett D.|Portable respiratory exercise apparatus and method for using the same| US5658221A|1995-02-10|1997-08-19|Hougen; Everett D.|Portable personal breathing apparatus and method of using same| EP0808197A4|1995-02-10|2001-03-28|Everett D Hougen|A portable, personal breathing apparatus| FR2733917B1|1995-05-12|1997-10-17|Benarrouch Jacques|OSCILLATORY PRESSURE VARIATOR TO REDUCE THE VISCOSITY OF THIXOTROPIC MUCUS FOR THEIR EXPECTORATION OF LUNGS AND BRONCHES| EP0862474A4|1995-09-18|2000-05-03|Resmed Ltd|Pressure control in cpap treatment or assisted respiration| US5823179A|1996-02-13|1998-10-20|1263152 Ontario Inc.|Nebulizer apparatus and method| US5899832A|1996-06-14|1999-05-04|Hougen; Everett D.|Compact lung exercising device| US5791339A|1997-03-13|1998-08-11|Nellcor Puritan Bennettt Incorprated|Spring piloted safety valve with jet venturi bias| SE9700938D0|1997-03-14|1997-03-14|Astra Ab|Powder inhaler II and a method of construction thereof| US5829429A|1997-04-21|1998-11-03|Hughes; Arthur R.|Acoustic respiratory therapy apparatus| US6058932A|1997-04-21|2000-05-09|Hughes; Arthur R.|Acoustic transceiver respiratory therapy apparatus| GB9709275D0|1997-05-07|1997-06-25|Hayek Zamir|Fluid control valve and oscillator for producing a pressure waveform| DE19720701A1|1997-05-16|1998-11-19|Gsf Forschungszentrum Umwelt|Device for applying a medicament aerosol via the lungs| US6044841A|1997-08-29|2000-04-04|1263152 Ontario Inc.|Breath actuated nebulizer with valve assembly having a relief piston| US6345617B1|1997-09-26|2002-02-12|1263152 Ontario Inc.|Aerosol medication delivery apparatus and system| US6293279B1|1997-09-26|2001-09-25|Trudell Medical International|Aerosol medication delivery apparatus and system| US6067984A|1997-10-14|2000-05-30|Piper; Samuel David|Pulmonary modulator apparatus| US5925831A|1997-10-18|1999-07-20|Cardiopulmonary Technologies, Inc.|Respiratory air flow sensor| US6026807A|1998-02-27|2000-02-22|Diemolding Corporation|Metered dose inhaler cloud chamber| US6066101A|1998-04-20|2000-05-23|University Of Maryland|Airflow perturbation device and method for measuring respiratory resistance| US6102038A|1998-05-15|2000-08-15|Pulmonetic Systems, Inc.|Exhalation valve for mechanical ventilator| JP3768689B2|1998-07-31|2006-04-19|スズキ株式会社|Ventilator| AUPP512398A0|1998-08-07|1998-09-03|Resmed Limited|A control member for a valve and method for determining fluid flow rate through a valve| AU1242600A|1998-11-06|2000-05-29|Salter Labs|Nebulizer mouthpiece and accessories| EP1170064A1|1998-12-25|2002-01-09|Kyowa Hakko Kogyo Co., Ltd.|Gas oscillatory wave generator| DE60029032T2|1999-05-28|2006-11-02|Integrated Biosystems, Napa|ACCELERATED DEFROSTING OF BIOPHARMETHIC SOLUTIONS USING OSCILLATION MOVEMENT| US6726598B1|1999-06-18|2004-04-27|Powerlung, Inc.|Pulmonary exercise device| US6606992B1|1999-06-30|2003-08-19|Nektar Therapeutics|Systems and methods for aerosolizing pharmaceutical formulations| US6615831B1|1999-07-02|2003-09-09|Respironics, Inc.|Pressure support system and method and a pressure control valve for use in such system and method| US6253766B1|1999-08-24|2001-07-03|Dhd Healthcare Corporation|Continuous positive airway pressure therapy device| US6708690B1|1999-09-03|2004-03-23|Respironics, Inc.|Apparatus and method for providing high frequency variable pressure to a patient| US6581596B1|1999-09-24|2003-06-24|Respironics, Inc.|Apparatus and method of providing high frequency variable pressure to a patient| US6910479B1|1999-10-04|2005-06-28|Advanced Respiratory, Inc.|Airway treatment apparatus with bias line cancellation| US6283118B1|1999-10-13|2001-09-04|Hsueh-Yu Lu|Ultrasonic nebulizer| US7059324B2|1999-11-24|2006-06-13|Smiths Medical Asd, Inc.|Positive expiratory pressure device with bypass| USD440651S1|1999-11-24|2001-04-17|Dhd Healthcare Corporation|Positive expiratory pressure device| US6776159B2|1999-11-24|2004-08-17|Dhd Healthcare Corporation|Positive expiratory pressure device with bypass| US6581598B1|1999-11-24|2003-06-24|Dhd Healthcare Corporation|Positive expiratory pressure device| US6240917B1|1999-12-20|2001-06-05|Joseph R. Andrade|Aerosol holding chamber for a metered-dose inhaler| US6412481B1|1999-12-23|2002-07-02|Robert Bienvenu|Sealed backpressure attachment device for nebulizer| US6447459B1|2000-04-07|2002-09-10|Pds Healthcare Products, Inc.|Device and method for measuring lung performance| DE60114393T2|2000-04-11|2006-04-27|Trudell Medical International, London|AEROSOL DISPENSER WITH A POSSIBILITY FOR POSITIVE EXHAUST PRINTING| US6369725B1|2000-09-26|2002-04-09|International Business Machines Corporation|Method for binary to decimal conversion| US6889564B1|2000-10-23|2005-05-10|Newved, Inc.|Peak flow meter| US6581595B1|2000-11-14|2003-06-24|Sensormedics Corporation|Positive airway pressure device with indirect calorimetry system| US6595203B1|2000-11-28|2003-07-22|Forrest M. Bird|Apparatus for administering intermittent percussive ventilation and unitary breathing head assembly for use therein| ES2375333T3|2001-03-20|2012-02-28|Trudell Medical International|NEBULIZING DEVICE.| US6851425B2|2001-05-25|2005-02-08|Respironics, Inc.|Exhaust port assembly for a pressure support system| US6681768B2|2001-06-22|2004-01-27|Sofotec Gmbh & Co. Kg|Powder formulation disintegrating system and method for dry powder inhalers| AT392228T|2001-06-27|2008-05-15|Fisher & Paykel Healthcare Ltd|EXHAUST VALVE FOR A NASAL VENTILATION MASK| US6581600B2|2001-07-13|2003-06-24|Forrest M. Bird|Interface apparatus and combination and method| IL145461A|2001-09-16|2006-09-05|Alyn Woldenberg Family Hospita|Inexsufflator| US6994083B2|2001-12-21|2006-02-07|Trudell Medical International|Nebulizer apparatus and method| US6702769B1|2002-01-07|2004-03-09|Medical Acoustics, Llc|Device and method for inducing sputum| GB0205760D0|2002-03-12|2002-04-24|Southbank University Entpr Ltd|Vibrationary exercise apparatus| US20070259759A1|2005-04-06|2007-11-08|South Bank University Enterprises Ltd.|Vibrationary exercise equipment| CN2577872Y|2002-11-15|2003-10-08|杜肇旭|Vibrational barometric respiratory therapeutic equipments| USD490519S1|2003-03-24|2004-05-25|Dhd Healthcare Corporation|Respiratory therapy device| US7360537B2|2003-04-16|2008-04-22|Trudell Medical International|Antistatic medication delivery apparatus| US20070089740A1|2003-04-28|2007-04-26|Chi, Llc|Pursed lip breathing device| DE20307306U1|2003-05-09|2003-07-24|Jump Health Co K|Medical, mechanical compressor atomizer| US7188621B2|2003-08-04|2007-03-13|Pulmonetic Systems, Inc.|Portable ventilator system| US8118024B2|2003-08-04|2012-02-21|Carefusion 203, Inc.|Mechanical ventilation system utilizing bias valve| US6929007B2|2003-09-08|2005-08-16|J.H. Emerson Company|Insufflation-exsufflation system with percussive assist for removal of broncho-pulmonary secretions| US7191780B2|2003-09-22|2007-03-20|Comedica Incorporated|Continuous high-frequency oscillation breathing treatment apparatus| CA2546331A1|2003-11-17|2005-05-26|Spirojet Medical Ltd.|Spirometer| CN2666403Y|2003-12-18|2004-12-29|周向东|Internal shocking respiratory tract cleaning device| WO2005093174A2|2004-03-25|2005-10-06|Neoperl Gmbh|Aerator for a plumbing fixture| EP1732623B1|2004-04-05|2014-07-16|Covidien LP|Surgical hand access apparatus| US7191776B2|2004-05-10|2007-03-20|Smiths Medical Asd, Inc.|Nebulizer breathing system| US7771472B2|2004-11-19|2010-08-10|Pulmonx Corporation|Bronchial flow control devices and methods of use| JP5230202B2|2004-12-08|2013-07-10|ヴェンタス・メディカル・インコーポレーテッド|Breathing device and kit| US7721729B2|2005-03-09|2010-05-25|Ric Investments, Llc|Nebulizing drug delivery device for ventilator| GB0507547D0|2005-04-14|2005-05-18|Ramer Ltd|Exercise device and methods of exercising| US7617821B2|2005-11-23|2009-11-17|Vibralung, Inc.|Acoustic respiratory therapy apparatus| EP1968674A4|2005-12-21|2013-05-01|Verathon Medical Canada Ulc|Secretion clearing patient airway management system| US8025051B2|2005-12-23|2011-09-27|Astrazeneca Ab|Delivery device| RU2306161C1|2006-01-24|2007-09-20|Яков Абраммерович Гольдштейн|Breathing training device| USD585977S1|2006-02-15|2009-02-03|Intelligent Medical Technologies Pty Limited|Nebuliser| US8460223B2|2006-03-15|2013-06-11|Hill-Rom Services Pte. Ltd.|High frequency chest wall oscillation system| US7909033B2|2006-05-03|2011-03-22|Comedica Incorporated|Breathing treatment apparatus| EP2026723B1|2006-05-23|2018-11-21|Theravent, Inc.|Nasal respiratory devices| GB2441584A|2006-09-05|2008-03-12|South Bank Univ Entpr Ltd|Breathing device| GB2441583A|2006-09-05|2008-03-12|South Bank Univ Entpr Ltd|Breathing device| USD558330S1|2006-09-13|2007-12-25|Merits Health Products Co., Ltd.|Nebulizer| US8051854B2|2006-09-15|2011-11-08|Comedica Incorporated|Continuous high-frequency oscillation breathing treatment apparatus| USD557405S1|2006-09-22|2007-12-11|Pre Holdings, Inc.|Spherical nebulizer| USD559975S1|2006-09-22|2008-01-15|Pre Holding, Inc.|Cylindrical nebulizer| USD558874S1|2006-09-22|2008-01-01|Pre Holding, Inc.|Spherical breath-enhanced nebulizer| USD560794S1|2006-09-22|2008-01-29|Pre Holding, Inc.|Cylindrical breath-enhanced nebulizer| US8225785B2|2006-10-03|2012-07-24|Smiths Medical Asd, Inc.|Vibratory PEP therapy system with medicated aerosol nebulizer| US7779841B2|2006-11-13|2010-08-24|Carefusion 2200, Inc.|Respiratory therapy device and method| EP2086618A2|2006-11-19|2009-08-12|Aespira Ltd.|Dry-powder inhaler| CN101932354B|2007-04-02|2013-06-19|阿利吉安斯公司|High frequency oscillation respiratory therapy device| US20080257348A1|2007-04-20|2008-10-23|Piper S David|Emergency and mass casualty ventilator| USD583046S1|2007-08-03|2008-12-16|Industrial Technology Research Institute|Nebulizer| WO2009105515A2|2008-02-21|2009-08-27|Trudell Medical International|Respiratory muscle endurance training device and method for the use thereof| KR101541209B1|2008-03-27|2015-07-31|맨카인드 코포레이션|A dry powder inhalation system| US8251876B2|2008-04-22|2012-08-28|Hill-Rom Services, Inc.|Breathing exercise apparatus| US8539951B1|2008-05-27|2013-09-24|Trudell Medical International|Oscillating positive respiratory pressure device| US8327849B2|2008-10-28|2012-12-11|Trudell Medical International|Oscillating positive expiratory pressure device| CN201329062Y|2009-01-21|2009-10-21|王纯丽|Draining phlegm equipment| US8485179B1|2009-02-23|2013-07-16|Trudell Medical International|Oscillating positive expiratory pressure device| US9149589B2|2009-02-23|2015-10-06|Trudell Medical International|Method and device for performing orientation dependent oscillating positive expiratory pressure therapy| US8539179B1|2009-03-31|2013-09-17|Symantec Corporation|Methods and systems for creating full backups| EP2444144B1|2009-06-17|2018-10-03|Mitsubishi Hitachi Power Systems, Ltd.|System for removing mercury and method of removing mercury from mercury-containing high-temperature discharge gas| WO2011058470A1|2009-11-13|2011-05-19|Koninklijke Philips Electronics N.V.|Method and device for airway clearance| EP2618877B1|2010-09-21|2015-02-11|Koninklijke Philips N.V.|Vibratory positive expiratory pressure device| EP2444114B1|2010-10-20|2016-09-28|Hill-Rom Services Pte. Ltd.|Apparatus for positive expiratory pressure therapy| EP2717953B1|2011-06-06|2018-08-08|Trudell Medical International|Oscillating positive expiratory pressure device| US9517315B2|2012-11-30|2016-12-13|Trudell Medical International|Oscillating positive expiratory pressure device| US9849257B2|2013-08-22|2017-12-26|Trudell Medical International|Oscillating positive respiratory pressure device| US10363383B2|2014-02-07|2019-07-30|Trudell Medical International|Pressure indicator for an oscillating positive expiratory pressure device| GB201412867D0|2014-07-19|2014-09-03|Smiths Medical Int Ltd|Respiratory therapy devices| US10449324B2|2015-07-30|2019-10-22|Trudell Medical International|Combined respiratory muscle training and oscillating positive expiratory pressure device| USD778429S1|2015-09-02|2017-02-07|Trudell Medical International|Respiratory treatment device| USD780906S1|2015-09-02|2017-03-07|Trudell Medical International|Respiratory treatment device|US8539951B1|2008-05-27|2013-09-24|Trudell Medical International|Oscillating positive respiratory pressure device| US8327849B2|2008-10-28|2012-12-11|Trudell Medical International|Oscillating positive expiratory pressure device| US8485179B1|2009-02-23|2013-07-16|Trudell Medical International|Oscillating positive expiratory pressure device| US9149589B2|2009-02-23|2015-10-06|Trudell Medical International|Method and device for performing orientation dependent oscillating positive expiratory pressure therapy| EP2717953B1|2011-06-06|2018-08-08|Trudell Medical International|Oscillating positive expiratory pressure device| JP6210981B2|2012-05-31|2017-10-11|旭化成株式会社|Cellulose powder| US9517315B2|2012-11-30|2016-12-13|Trudell Medical International|Oscillating positive expiratory pressure device| US9833584B2|2013-03-22|2017-12-05|Breathe Technologies, Inc.|Portable ventilator secretion management system| GB201310824D0|2013-06-18|2013-07-31|Smiths Medical Int Ltd|Respiratory therapy apparatus and methods| US10272224B2|2013-07-12|2019-04-30|Trudell Medical International|Huff cough simulation device| US9849257B2|2013-08-22|2017-12-26|Trudell Medical International|Oscillating positive respiratory pressure device| GB201400188D0|2014-01-07|2014-02-26|Smiths Medical Int Ltd|Respiratory therapy apparatus| US10363383B2|2014-02-07|2019-07-30|Trudell Medical International|Pressure indicator for an oscillating positive expiratory pressure device| GB201407571D0|2014-04-30|2014-06-11|Smiths Medical Int Ltd|Respiratory therapy devices| USD796664S1|2014-05-13|2017-09-05|Khalil A Hill|Visual flow indicator rotating nebulizer| USD779071S1|2015-08-14|2017-02-14|Christopher D. Warner, III|Positive expiratory pressure device| USD773645S1|2014-12-12|2016-12-06|Wen-Ching Lee|Nebulizer| US10004872B1|2015-03-06|2018-06-26|D R Burton Healthcare, Llc|Positive expiratory pressure device having an oscillating valve| USD790683S1|2015-03-11|2017-06-27|Resmed Limited|Pressurized air delivery console| USD781412S1|2015-04-09|2017-03-14|Celon Pharma S.A.|Inhaler| US10449324B2|2015-07-30|2019-10-22|Trudell Medical International|Combined respiratory muscle training and oscillating positive expiratory pressure device| USD778429S1|2015-09-02|2017-02-07|Trudell Medical International|Respiratory treatment device| USD780906S1|2015-09-02|2017-03-07|Trudell Medical International|Respiratory treatment device| WO2017095978A1|2015-12-01|2017-06-08|Teleflex Medical Incorporated|Positive expiratory pressure therapy apparatus with magnetic components| EP3383465B1|2015-12-04|2021-02-03|Trudell Medical International|Huff cough simulation device| USD844787S1|2015-12-28|2019-04-02|Resmed Limited|Pressurized air delivery console| CN106924852B|2015-12-29|2019-06-21|北京谊安医疗系统股份有限公司|A kind of flap valve cover| USD857189S1|2016-03-11|2019-08-20|ResMed Pty Ltd|Battery pack for an air delivery module| USD882068S1|2016-04-19|2020-04-21|Xenios Ag|Gas exchange medical apparatus| USD827921S1|2016-05-27|2018-09-04|Ghost Herbal Concepts Ltd|Personal vaporizer| AU201617332S|2016-06-30|2017-01-23|Ghost Herbal Concepts Ltd|Personal vaporiser| USD822895S1|2016-06-30|2018-07-10|Ghost Herbal Concepts Ltd|Personal vaporizer| CA3028604A1|2016-07-08|2018-01-11|Trudell Medical International|Smart oscillating positive expiratory pressure device| USD808007S1|2017-03-14|2018-01-16|Martega Group Ltd|Wearable inhaler| CA3059532A1|2017-05-03|2018-11-08|Trudell Medical International|Combined oscillating positive expiratory pressure therapy and huff cough simulation device| USD874006S1|2017-06-15|2020-01-28|Aerofit.Dk Aps|Respiratory exercise device| AU2019205865A1|2018-01-04|2020-07-16|Trudell Medical International|Smart oscillating positive expiratory pressure device| US20190209797A1|2018-01-09|2019-07-11|Encite Llc|Micro bi-Directional Valves and Systems| US10953278B2|2018-02-02|2021-03-23|Trudell Medical International|Oscillating positive expiratory pressure device| KR101907099B1|2018-05-18|2018-10-11|쓰리에스|Portable apparatus for discharging expectoration with exhalation sensing function| KR101907093B1|2018-05-18|2018-10-11|쓰리에스|Portable apparatus for discharging expectoration| ES2756873B2|2018-10-25|2021-05-14|Yanez Tous Jose|HIGH SENSITIVITY DOUBLE CLAP ANTI-RETURN VALVE| USD875237S1|2019-04-18|2020-02-11|Firas Kasem Ghazzawi|Resistance breathing device| US10780318B1|2019-04-18|2020-09-22|Firas Kasem Ghazzawi|Breathing device with exhale and inhale valve to create resistance| CN110548259B|2019-10-09|2020-10-09|杨雪|Paediatrics respiratory rehabilitation training device| CN113082611A|2021-04-12|2021-07-09|李占军|Medical rehabilitation equipment|
法律状态:
2018-12-11| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]| 2019-10-01| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]| 2020-08-25| B09A| Decision: intention to grant [chapter 9.1 patent gazette]| 2020-12-08| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/06/2012, OBSERVADAS AS CONDICOES LEGAIS. |
优先权:
[返回顶部]
申请号 | 申请日 | 专利标题 US201161493816P| true| 2011-06-06|2011-06-06| US61/493,816|2011-06-06| US201161532951P| true| 2011-09-09|2011-09-09| US61/532,951|2011-09-09| PCT/IB2012/001089|WO2012168780A2|2011-06-06|2012-06-06|Oscillating positive expiratory pressure device| 相关专利
Sulfonates, polymers, resist compositions and patterning process
Washing machine
Washing machine
Device for fixture finishing and tension adjusting of membrane
Structure for Equipping Band in a Plane Cathode Ray Tube
Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein an
国家/地区
|